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ABSTRACT 
This study examined whether immediate (I) vs. delayed (D) protein intake 
following exercise influenced fractional synthesis rate (FSR) and other health/fitness 
markers during a Resistance Interval Program (RIPT) exercise & weight management 
intervention.  21 sedentary women (59.8±5 yrs, 43.7±3% body fat, 31.0±3 kg/m2) 
participated in a 12 week Curves Complete® program [followed an energy-reduced diet 
(1,500 kcal/d; 30% C, 45% P, and 25% F) while participating in circuit resistance 
exercise (RE) (30min; 3d/wk) and walking (10k steps, 4/d wk)].  Each ingested 15 g of 
protein immediately post (I) or 2 hours post (D) RE.  Body composition, body mass, 
resting energy expenditure (REE) and FSR [determined using a deuterium oxide (2H2O 
or D2O) ingestion and muscle biopsy protocol] were examined.  Data were analyzed by 
repeated measures MANOVA and/or ANOVA, and are presented as changes from 
baseline after 4, 8, and 12 wks [body composition, body mass, resting energy 
expenditure (REE)]; 0 and 12 weeks (FSR) for the I and D groups, 
respectively.  Significant time effects were observed (body mass, fat mass, and body fat) 
yet no significant group x time effects resulted.  The D group generally experienced 
more favorable body mass (I -2.0±1.0, -2.7±1.6, -3.6±2.2; D -2.2±2.5, -3.6±3.6, -
4.2±4.2, kg, p=0.59), fat mass (I -1.7±1.0, -2.4±1.5, -3.5±1.5; D -2.8±1.7, -3.4±2.6, -
4.8±3.3, kg, p=0.32), FFM (I -0.3±2.0, -0.1±2.0, -0.0±1.7; D 0.92±1.4, 0.4±1.7, 1.1±1.3, 
kg, p=0.24), and % body fat (I -1.2±2.1, -1.8±2.1, -2.8±1.9; D -2.6±1.9, -2.8±2.6, -
4.4±3.1 %, p=0.25) changes.  No REE differences were seen among groups (I -18±146, -
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101±163, -82±126; D -46±137, -17±173, -90±142 kcal/d, p=0.34).  No significant 
nutrient timing x training interactions (mean±SEM) were observed in muscle FSR 
expressed as percent/day of the alanine pool (I-Pre 13.6±4.3, I-Post 21.1±4.3; D-Pre 
15.6±4.0, D-Post 23.8±4.0 %/d, p=0.93).  However, FSR was upregulated (p<0.05) in 
response to a pre-training bout of RE (14.6±2.9 %/d), and trended 54% higher (p=0.075) 
in response to post-training values (22.5±2.9 %/d).  Results indicate that the program 
was effective in promoting weight and fat loss, while maintaining FFM.  Post exercise 
FSR increased pre-training, and trended higher at 12-wks.  However, while some trends 
were observed warranting additional study, no statistically significant differences were 
seen between the I and D nutrient timing strategies 
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CHAPTER I 
INTRODUCTION AND RATIONALE 
 Estimates of the number of obese American adults have been steadily expanding 
from 19.4% in 1997, to 24.5% in 2004 [1], 26.6% in 2007[2].  Previously, 75% of adults 
in the United States were projected to be overweight, and 41% obese by 2015 [3].  
According to recent CDC figures, we currently stand at ~36.5%.  That said, the 
beneficial effects of appropriate exercise have the ability to offset mortality rates, as well 
as positively affect body composition [4], and have been well-documented [5-8].  As our 
population ages, a significantly related consequence is sarcopenic obesity, which has 
been defined as gain in weight without concomitant gain in lean tissue [9,10].  This loss 
of muscle mass and strength has been implicated as impacting metabolic disorders (i.e., 
insulin resistance) as well as significantly affecting functional capacity throughout the 
aging process [11-14].   
  Hypertrophy of skeletal muscle tissue (an increase in myofiber diameter) is 
characterized by increased contractile force and augmented protein synthesis [15], and is 
consistently reported following resistance exercise.  Along with an associated increase in 
protein synthesis, skeletal muscle hypertrophy is mediated by synergistic interactions as 
a result of mechanical, hormonal, and nutritional interventions [16].  Acute post 
resistance exercise (RE) increases in muscle protein synthesis (MPS) from 1-48 hours in 
humans has been well-documented [17-21].  The accepted theory behind muscle 
hypertrophy resulting from resistance exercise training (RET) is that the anabolic effects 
are cumulative.  Nevertheless, as compared to acute RE, chronic RET may result in an 
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attenuation of the muscle protein synthesis (MPS) response [22-25].  Additionally, acute 
MPS may be attenuated in older men [26,27].  Understanding the impact of protein 
synthesis in response to such dynamic stimuli should enhance the understanding of basic 
functional & applied muscle physiology, contributing to more effective post-resistance 
exercise nutrition strategies.  Subsequent implications for these age related fitness and 
functional interventions may be invaluable. 
 Practically, this information may be enlisted to optimize the anabolic hormonal 
response of resistance exercise through ingestion of macro and/or micronutrients [28].  
The combination of RE with nutrition appears to facilitate a potent beneficial interaction 
between anabolic stimulation, and a concomitant attenuation of skeletal muscle 
breakdown [28-34].  Although meal intake alone has been reported to increases human 
muscle protein synthesis, it is believed that extra-cellular amino acid concentrations 
supplied by the diet mediate this response [35-37].  Post-prandial hormone secretion 
(insulin) supports this process, primarily by inhibiting protein breakdown [38-40].  Post-
absorptive RE has been reported to increase mixed muscle [17,20-23,25,41-43], 
myofibrillar [23,43] and sarcoplasmic [44] protein synthesis in animals and humans, 
while (understandably) concomitantly facilitating breakdown [20].  
 Recent nutrient timing studies have shown recovery and protein synthesis 
benefits in younger, more athletic populations [45-49], yet similar studies targeting 
aging, overweight female populations are relatively sparse.  Two longer (12 weeks) 
studies [50,51] have supported the notion that protein consumption in the early period 
following resistance exercise is paramount for optimal muscle growth in senior men and 
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women.  Interestingly, several acute RE investigations which directly measured MPS 
with macronutrient intake before [32,47,52-55], during [34,56], or after [28-31,47,54,57] 
exercise have reported mixed results.  Recent research seems to suggest that an 
improved anabolic profile may remain available for around 2 hours post-exercise 
[49,58,59]. 
Strength nutrition applications [60] including liquid carbohydrate (CHO) and 
protein (PRO), both whole foods (milk) and specific PRO fractions (whey and casein), 
amino acid constituents [essential amino acids (EAA) and branch chain amino acids 
(BCAA)], as well as mixed nutrient ingestion (CHO/PRO) have steadily gained 
popularity [61].  The availability of EAA following exercise, especially BCAA, (often 
leucine in particular) has been reported to influence recovery by optimizing protein re-
synthesis (as well as glycogen re-synthesis) rates after exercise [31,54,58,59,62,63].  
However, most investigations have used a fasted subject population, which is obviously 
neither practical, nor optimal during normal free-living conditions. 
Previous work in the ESNL [64] has shown that older women, following a higher 
protein diet while participating in a circuit training program showed significant fat mass 
(FM) loss while maintaining fat free mass (FFM).  Theoretically, timed nutrient intake 
after exercise may preserve and/or promote increased FFM in aging women attempting 
to lose weight.  In particular, the insidious health concerns of post-menopausal women 
(sarcopenia, increasing obesity, stroke, cancer, diabetes, hormonal imbalances etc.), 
suggests our population of interest may stand to gain valued benefit from any nutrient 
timing effect.  Therefore, utilizing the 2H2O stable tracer methodology described in 
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chapters 2 & 3, we seek to explore the acute & chronic effects of post exercise timed 
nutrition (via a commercially available shake) using 20 overweight untrained to trained 
aging women (50-70 years) following an energy and macronutrient controlled diet over 
12 weeks of moderately intense circuit training on: FSR, resting energy expenditure 
(REE), general body composition, and muscular strength.  The results of this study 
should offer an important contribution toward determining whether timed post exercise 
nutrition would be an effective nutritional intervention for optimal anabolic dividends in 
overweight/obese aging women. 
Statement of the Problem 
Does timed post exercise nutritional intake significantly affect markers of 
training adaptation for aging overweight/obese women on a higher protein diet 
participating in a 12-week circuit-training program? 
Purpose of the Study 
The purpose of this study was to determine if timed post exercise nutritional 
intake significantly affects protein synthesis and/or training adaptations in aging 
overweight/obese women on a high protein diet participating in a circuit training 
program. 
General Study Overview 
 Twenty overweight to obese (~ 27+ BMI) aging women (50-70 years) who met 
screening and health approval criteria were randomly assigned to one of two groups for 
participation in a higher protein diet & exercise program.  The early timed nutrition (I) 
group (n=10) received immediately post exercise nutrition, while the delayed timed 
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nutrition (D) group (n=10) were instructed to ingest the same nutrition 2 hours post 
exercise.  The independent variable is the nutrient timing.  The dependent variables 
include: body composition [weight, FM, FFM, percent body fat (BF)]; REE, upper body 
[bench press (BP)] and lower body [leg press (LP)] strength & endurance; and skeletal 
muscle protein synthesis [fractional synthesis rate (FSR)] as measured via biochemical 
analysis of the collected blood serum & muscle biopsy tissue samples.  Blood was drawn 
for monitoring metabolic pools for the FSR, via 2H2O analysis.  Statistical analyses were 
performed for body composition parameters, FSR, upper/lower body (BP & LP) 
strength, and REE. 
Hypotheses 
 Based on the volume of published research studies cited, and the variables 
denoted herein, the following hypotheses were evaluated: 
HA1:  Timed nutrition will significantly enhance pre training FSR in the 
           I compared to the D group. 
HA2:  Timed nutrition will not significantly enhance post training FSR of the 
           I compared to the D group. 
HA3:  Timed nutrition will significantly enhance FM loss in the I compared to 
 the D group over time. 
HA4:  Timed nutrition will significantly enhance FFM gain in the I compared to 
 the D group over time. 
HA5:  Timed nutrition will significantly improve upper body strength in the I 
 compared to the D group over time. 
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HA6:   Timed nutrition will significantly improve lower body strength in the 
           I compared to the D group over time. 
 HA7: Timed nutrition will significantly improve REE in the I compared to 
 the D group over time. 
Delimitations 
 The research study followed guidelines listed below: 
1. Approximately 20 sedentary overweight, but otherwise relatively 
      healthy post-menopausal female participants (BMI ~ 27+) participated in this 
study.  Participants were screened, and medically cleared by a physician 
when necessary as determined by ACSM guidelines. 
2. Participants were recruited using flyers posted on the University campus, and 
      physician offices/clinics.  Advertisements were run in the campus & local 
      newspapers, and/or radio segments.   
3.  Familiarizations and testing sessions were conducted in the Exercise and 
Sport Nutrition Laboratory (ESNL), and the Human Countermeasures 
Laboratory at Texas A&M University.   
4.  Participants were randomly assigned to one of two treatment groups (I or D).   
Limitations 
1.   Participants were sedentary and overweight post-menopausal (50-70 years) 
females (BMI ~ 27+) who met medical clearance qualifying criteria and were 
able to seek physician approval if necessary. 
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2.  Participants were required to adhere to the Curves 30 minute fitness program 
as described during pre-study familiarization & screening throughout the 12 
week investigation.  
3.  Participants were required to follow the Curves International Fitness &Weight 
Management Program within a free-living environment.   
4.  Participants were required to honestly complete forms and questionnaires 
legibly, and follow the prescribed regimens as outlined throughout the 
recruitment, familiarization, and participation processes.  
5. Participants completed the Eating Satisfaction Survey, which has not been 
proven valid or reliable. 
6. The sensitivity and specificity of the laboratory procedures utilized to identify 
changes in the criterion variables are subject to quantified limitations.  
Unavoidable variations in testing times, dietary intakes, 
metabolic/physiological status etc. due to a model system involving free-living 
humans is a limitation. 
7. Participants were drawn from a convenience sample at the Texas A&M 
campus and from surrounding communities, thus somewhat limiting the 
ability to infer results to a larger population. 
Assumptions 
1.  Participants followed the Curves Fitness & Weight Management Program as 
specified by the assigned diet regimen. 
2.  Participants adhered to verbal and written instructions, on more than one occasion, 
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to refrain from exercise for 48 hours prior to all testing sessions. 
3.  Participants followed instructions to refrain from dietary intake (with the exception 
those randomly assigned to the I group) for at least two hours pre & post exercise. 
4.  Participants followed instructions to fast for a minimum of 12 hours prior to all 
appropriate testing sessions. 
5.  Participants followed the intensity guidelines for all workouts per coach’s 
instructions, and as guided via the Curves Smart technology. 
6.  All assay methods & equipment used in the analysis of blood and muscle samples 
were accurate and reliable in quantification of dependent variables.   
Relevant Terminology 
1. Adiposity - usually refers specifically to tissue made up primarily of fat cells such as 
the yellow layer of fat beneath the skin. 
2. Anthropometry - the study of human body measurement for use in anthropological 
classification and comparison. 
3.  Anthropometric measures - measures of or relating to anthropometry. 
4. Bioelectrical Impedance Analysis (BIA) – body composition assessment technique 
whereby a small current of electricity is passed between electrodes placed on the 
body, thereby quantifying the volume of body water and body fat.  
5. Body Composition - Test used to determine body fat percentage. 
6. Body Mass Index (BMI) - statistical measure of the weight of a person scaled 
according to height defined as kilograms per meter squared. 
7. Food Record (Log) - Form used to record all fluid and food intake during a specified 
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period in order to standardize nutritional intake. 
 8. Deuterium (Heavy Water; D2O, or 2H2O) - Heavy water is water that contains a 
higher proportion than normal of the isotope deuterium, as deuterium oxide, D2O or 
      ²H2O.   
 9. Dual-Energy X-Ray Absorptiometry (DEXA) - Procedure used for limited x-ray 
technology to determine body composition and bone mineral density.  
10. Eating Satisfaction Survey - a questionnaire used to determine eating satisfaction of 
an assigned diet.  
11. Elderly - of or pertaining to persons in later life. 
12. Fat Free Mass (FFM) – Typically refers to lean muscle tissue. 
13. Fat Mass (FM) - Term used to describe the fat weight of the human body.     
14. Fractional Synthesis Rate (FSR) – quantification method for the rate of protein 
synthesis.  FSR = EA /(EBW∙ 3.7 · t), where EA represents amount of protein-bound 2H 
       Ala (%), EBW is the quantity of 2H2O in body water (%), 3.7 represents the exchange  
Of 2H between body water and alanine, and t is time of label exposure. 
15. Gerontology - the study of aging. It is to be distinguished from geriatrics, which is 
the study of the diseases of the aging. 
16. Isotonic Exercise – involves movements with constant external resistance.  The 
amount of force required to move the resistance varies depending, primarily, on the 
angle and length of each agonist muscle.     
17. Gas Chromatography-Mass Spectrometry (GS MS) - in combination with 
isotopic labeling of metabolic compounds, the GC-MS is used for determining 
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metabolic activity. GC MS is an analytical technique for the determination of the 
elemental composition of a sample.  It is also used for elucidating the chemical 
structures of molecules, such as peptides and other chemical compounds. 
18. Macronutrient – carbohydrate, lipid, and protein nutrients.     
19. Micronutrient – small quantities of vitamins & minerals that facilitate energy 
transfer and tissue synthesis.     
20. Modified Bruce Protocol- A standardized multistage treadmill test for assessing 
cardiovascular health.  An alteration of the Bruce protocol 
21. Mole Percent Excess - A quantitative measure of the concentration of a stable  
isotope, analogous to the specific radioactivity of a radioisotope; the enrichment of 
that isotope, as a percentage of all isotopes, over and above its usual occurrence in 
nature.  
22. Psychometric Assessments - Questionnaires completed by participants to  
determine the eating satisfaction and quality of life throughout the length of the 
study. 
23. Quality of Life (QOL/SF-36) - Questionnaire used to measure health-related quality 
of life by assessing eight different dimensions:  physical functioning, role limitations 
caused by physical health problems, bodily pain, general health perceptions, 
energy/fatigue, social function, role limitation caused by emotional problems, and 
emotional well-being.       
24. Sarcopenic Obesity - the combination of obesity and loss of muscle mass. 
25. Senior - of, for, or pertaining to a senior citizen, or senior citizens as a group. 
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26. Total Body Water (TBW) - The sum of intracellular water and extracellular water 
      (volume), about 60% of total body weight.   
27.  VAT – Visceral Adipose Tissue. 
28. Waist to Hip Ratio (WHR) - waist circumference divided by hip circumference.   
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CHAPTER II 
LITERATURE REVIEW 
Aging in the U.S. 
One of the fastest growing segments of developed countries is felt to be those 
aged 65 and over.  Currently this group accounts for approximately 15% of the 
population in western European countries and the United States.  The proportion is 
expected to grow to 19%-26% by the year 2025, and it becomes clear that it is especially 
important to focus on obesity in the elderly, due to the effects on morbidity and mortality 
compared to younger individuals [65].  Addressing health concerns during the early 
aging stages should make a significant impact on overall health as our population ages.  
It is also important to note that due to the incidence of co-morbid conditions in this 
population, obesity intervention plays a key role in the management of these diseases 
[66].  A 1993 study found that 14 percent of all deaths in the United States were felt to 
be attributed to inadequate nutrition and insufficient activity [67].  
The Centers for Disease Control (CDC) data has reported that 28-34 percent of 
adults aged 65-74, and 35-44 percent of those aged 75 or older are inactive (defined as 
no leisure-time physical activity).  Their findings also suggest that older people are more 
inactive than those persons who are middle aged [66]. 
National data tracked by the U.S. Department of Health and Human Services 
supports that few older persons engage in regular physical activity.  Thirty one percent 
of Individuals aged 65 to 74 years reported 20 minutes of moderate physical activity on 
three or more days per week, while approximately 16% reported 30 minutes of moderate 
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activity on 5 or more days per week [68].  Vigorous physical activity that produces large 
increases in heart rate and moderately heavy sweating produces greater gains in 
cardiopulmonary fitness.  Individuals that participate in vigorous activity are even fewer 
in number, and continue to decline with age [66].   The estimates for 2000 indicate only 
13% of individuals aged 65 to 74 reported engaging in vigorous physical activity for 20 
minutes three or more days per week.  There were only six percent of those age 75 and 
older reporting vigorous physical activity [68]. 
 Even midlife increases in physical activity, through change in occupation or 
recreational activities, have been associated with a decrease in mortality [69-72].  
Despite this evidence, the vast majority of adults in the United States remain effectively 
sedentary.  A 2003 study reported that less than one-third of Americans met the minimal 
recommendations for activity as outlined by the CDC, ACSM, and AHA expert panels 
[73]. 
 The growing number of aging, obese adults puts increased demands on medical, 
social, and public health system services.  The total US combined costs of overweight 
and obese in the year 2000 was estimated at $117 billion [68].  Of this number, eighteen 
percent of adults aged 65 and older were obese.  This data also showed that another 40 
percent were overweight.  As the American population grows in number and the 
percentage of elderly increase, medical care costs will also continue to rise.  The CDC 
has shown that the cost of inactive adults is substantially higher than those of their active 
counterparts (Figure B1, pg. 131).  More recent research continues to emphasize 
increasing costs of healthcare in aging populations with decreased physical activity and 
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disability [74-76].  The excess costs are especially notable in women.  Data suggests that 
improving physical activity in elderly women stands to reap more benefits in terms of 
lower health care costs as compared to any other age group [66].   
Obesity in the Aging Population 
 The definition of obesity currently relies upon Body Mass Index as a tool for 
assessing weight status.  Both the National Heart, Lung and Blood Institute of Health 
(NHLBI) of the National Institute of Health (NIH) and World Health Organization 
(WHO) now recommend 25 kg/m2 as the upper limit of ideal body weight for all adults 
regardless of age [77].  Parameters for normal weight and obesity in the elderly are often 
disputed in the literature due to potential adverse effects of weight loss such as muscle 
wasting, nutritional deficits and disease states.  A meta-analysis [78] concluded that the 
federal guidelines for ideal weight (BMI 18.7 to < 25) might be too limiting for older 
adults.  They determined that a BMI ranging from 27-30 are optimal based on all-cause 
and CHD mortality and CHD incidence.  Some experts support the definition of obesity 
in the elderly as a BMI > 30.  Figure B2 (pg. 133) shows the US median BMI by age 
from 1990-2000. 
 There is some debate over ideal body weight due to the concern that senior adults 
may benefit more from maintenance of activity versus weight loss.  The concern is due 
to obesity related conditions that may be worsened such as sarcopenia and bone density 
changes during weight loss [79].  Due to these discrepancies and decreased reliability of 
BMI in the elderly, researchers have suggested the use of a more precise measure of 
body fat in the older population.  Hence, methods that measure three, four and/or five 
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compartments are recommended [79].  This study will utilize a multi-compartment 
method for assessing body composition changes (e.g., Bioelectrical Impendence (BIA), 
Dual Energy X-Ray Absorptiometry (DEXA), waist and hip measure etc.).   
Physiology of Aging and the Effects of Exercise 
 The process of aging can impair the body’s ability to regulate its internal 
environment.  While this process occurs in all individuals, exercise can offset some of  
the effects of aging.  The body systems and related effects of aging are represented in 
Table A1 (pg. 127) which illustrates how aging affects many physiological processes. 
 The onset of these changes usually begins in the third and fourth decade of life 
and continues to deteriorate with aging.  Fortunately for humans, the body system has 
been shown to respond quickly despite advanced age.  Obesity in the absence of 
intervention complicates and produces further stress on a body system and leads to 
cellular and system malfunction, ultimately producing a disease state.  Research has 
shown many times over that obesity is associated with increased risk of many common 
& chronic disease states including heart disease, stroke, some cancers and diabetes 
mellitus as well as disease risk factors such as hypertension and hyperlipidemia [80].  
Obesity has also been linked as a co-morbidity in a milieu of related and seemingly 
unrelated conditions such as osteoarthritis, gallstones, asthma, depression, and sleep 
disorders [81-86].   
 Research has repeatedly shown that exercise and the resultant weight manage-
ment can improve or mediate such conditions.   Resistance training impedes the rate of 
sarcopenia [87-94] (see below) [94], and may also substantially improve physical 
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function  [95].  An examination of the association between physical activity (PA) and 
visceral adipose tissue (VAT) in older adults conducted by Riechman, et.al. (2002) 
reported mean visceral, subcutaneous, total adipose, and visceral percent adipose tissue 
were all higher in older (64.5 ± 5.2 years) men and women subjects reporting physical 
difficulties (PD).  Reported trends for these mean differences were significant for all 
comparisons except for subcutaneous adipose in women, and visceral percent adipose 
tissue in men (as well as the total cohort).  The study suggests however, that age was 
only “weakly” associated to increased VAT and decreased subcutaneous adipose, which 
resulted in a significant association of age to visceral percent adipose tissue.  Hence, the 
accumulation of the relative VAT which accompanies aging in many, may contribute to 
the exacerbation of PD [96].  Hence, it stands to reason that any intervention which 
enhances FFM, and reduces FM should have a positive impact on overweight female 
populations which might experience a reduction in PD’s associated with VAT. 
 In the human aging process, there is a significant decline in neuromuscular 
function and performance.  One main characteristic of this decline is the inevitable 
reduction in skeletal muscle mass, and the associated loss of strength that occurs even in 
the healthy elderly [97].  This prevalent, physiological specter of aging is a condition 
called sarcopenia.  Sarcopenia is defined as loss of muscle mass and strength, and is 
generally considered to be a result of disuse.  However, the loss of muscle mass can be 
accelerated by inadequate nutrition and chronic illness.  The loss of muscle mass is 
currently felt to be approximately 5% per decade after the 4th decade of life, and 
currently thought to occur more rapidly after age 65 [98].  More importantly for this 
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study, it is also currently reported that the impact of muscle loss and function in women 
may be greater due to a lower initial muscle mass compared to men [98].   
 Table A2 (pg. 128) depicts a simplified summary of the alterations in muscle 
physiology with aging and post exercise intervention.  The advancement of techniques 
such as muscle fiber typing has allowed for increased knowledge in the area of muscle 
fiber changes through the lifespan and in studying training adaptations.  ATPase staining 
techniques are utilized to assess changes in Type I and II muscle fibers and their 
respective phenotypes.  Type I fibers are predominantly comprised of myosin heavy 
chain 2a (MHC 2a), and type IIB fibers are predominantly myosin heavy chain 2x (MHC 
2x).  One study reports that mRNA levels of MHC 2a and 2x decrease with age [99].  
Slow twitch type I fibers are fatigue resistant with greater oxidative capacity, higher 
mitochondrial content, and greater capillary density.  Type II fibers are fast-twitch fibers 
with a high glycolytic capacity.  Type II fibers can be classified into type IIA, having 
intermediate oxidative and glycolytic capacity and are more fatigue resistant.  Types IIB 
and IIC are more glycolytic.   
 In a comprehensive study looking at muscle fiber changes in the vastus lateralis, 
commonly used as a site for muscle tissue biopsy, 43 male cadavers examined between 
the ages of 15-83, showed an age-related loss in fiber number.  Between the ages of 20 
and 80 there was a reported 50% reduction in the total fiber number [100].  This loss has 
been noted to be more rapid over the age of 50.  Measurements of a cross sectional area 
of muscle, show a selective loss of fast-twitch type II fibers in comparison to slow-
twitch type I fibers.  This shift in aging appears to be independent of vigorous endurance 
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exercise based on muscle biopsies taken from a 20-year longitudinal study of distance 
runners [101].  The metabolic consequences of muscle mass decline have been well 
documented in a number of cross-sectional and longitudinal studies.  The reduction in 
muscle mass significantly affects the amount of metabolically active cell mass.  Previous 
research supports a 15% decline in resting metabolic rate between age 30 and 80 [101-
103].  This reported rate of decline may be seen as corresponding with an estimated 
caloric needs decrease of ~250kcal per day.  
A decline in total energy expenditure is also impacted by a decrease in physical 
activity.  The decline in physical activity is often due to age-related muscle weakness, 
fatigability, and loss of endurance.  Concomitantly, the loss of muscle mass (FFM) in 
aging is accompanied by gains in fat mass (FM).  This process is exacerbated by a 
decreased daily expenditure/physical activity, and a resultant decline in function which 
adds to the age-related accumulation of visceral & total body fat, as well as decreased 
insulin sensitivity.  This constellation of changes increases the likelihood of Type II 
Diabetes [104].  Due to the loss of muscle mass in the elderly, which serves as the main 
metabolic organ responsible for glucose disposal and fatty acids post meals, post 
prandial hyperglycemia is also more common in this population [98].  
The balance between protein synthesis and protein breakdown is the main 
contributor to the maintenance and repair of skeletal muscle.  Muscle quality and mass 
are reliant upon the efficient synthesis of new structural proteins.  Previous research has 
shown that the synthesis of mixed muscle protein is reduced by 30% with age 
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[26,99,105].  It is proposed that this conditionally selective decrease in muscle protein 
synthesis may explain the age-related decrease in muscle mass [98].        
 The number and function of mitochondria have been associated with the degree 
of muscle fatigability, reduced endurance capacity, and possibly loss of strength.  The 
ATP generated by mitochondria play a crucial role in generating contractile force.  It has 
been shown that aerobic exercise can significantly increase mitochondrial enzyme 
activity.  In men and women aged 60-70 who trained for 9-12 months by walking or 
jogging at 80% of maximal heart rate for 45 minutes, 4 days per week had a 24% 
increase in the mitochondrial enzymes succinate dehydrogenase, citrate synthase, and 
beta-hydroxyaacyl-CoA dehydrogenase [106].   
 The phenomenon “anorexia of aging” is suggested to be one of the most 
modifiable variables in the development, and progression of sarcopenia [97].  This 
condition is simply defined as the decline of food intake over the lifespan.  From 
differing perspectives between two separate papers, a steady dietary supply of protein 
may or may not provide sufficient (or optimal) support for mature adults pursuing 
maintenance or enhancement of FFM [51,107] (an area of interest that is central to the 
purpose of study).  There are many complex mechanisms and interactions that contribute 
to decreased food intake, including: early satiety secondary to decreased relaxation of 
the stomach, increased release of cholecystokinin (stimulates digestion of fat/protein) in 
response to fat intake, and increased leptin (appetite suppression) levels.  The elevation 
of leptin levels are thought to be in part due to increased fat mass with aging.  Other 
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contributors include effects of neurotransmitters such as opioids and neuropeptides 
[108].      
 Hormone therapy has also shown promise in combating age related muscle mass 
loss.  The hormones that have received the most attention include testosterone, growth 
hormone (GH), Insulin-like growth hormone (IGF-1) and dehydroepiandrosterone 
(DHEA) [98].  Bioavailable levels of testosterone have been shown to be decreased, 
especially in the years immediately following menopause.  Testosterone 
supplementation in elderly women appears to be an area which lends itself to further 
study [98].  In post hysterectomy patients with oopherectomy, bioavailable testosterone 
levels have been noted to be even lower due to the loss of ovarian androgen production 
[109,110].  Women taking estrogen replacement therapy may have a further reduction in 
bio-available testosterone by binding more androgen. 
 Studies have reported that growth hormone and its peripheral mediator, IGF-1, 
decrease with age [111-113], and the effects of growth hormone continue to be of 
interest [114,115].  Deficiency in growth hormone leads to muscle mass loss and 
increased adipose tissue.  The benefits and effects of growth hormone replacement in the 
elderly continue to be controversial.  Supplementation with recombinant growth 
hormone or IGF-1 in elderly women has been noted to increase net protein synthesis 
[116].  These changes may lead to increased muscle mass.  A 2003 study in elderly 
males failed to show beneficial effects from growth hormone in relation to muscle 
protein synthesis or strength compared to exercise alone [98].  It is also important to note 
the significant adverse effects due to growth hormone administration that contribute to 
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study withdrawal.  These adverse effects may include fluid retention, carpal tunnel 
compression, gynecomastia, and arthralgias [117,118].   
 DHEA and DHEA-S (DHEA sulfated form) are produced by the adrenal cortex.  
Although the exact practical biological role of these hormones has not been thoroughly 
examined, early studies have suggested that DHEA levels slowly decline after the 
second decade of life.  The decline is linear, and felt to be approximately 10% per 
decade until age 80 when the decline seems to accelerate [119-121].  Research on DHEA 
supplementation has produced mixed findings.  It is currently thought to have no effect 
on insulin sensitivity, resting metabolic rate, total energy expenditure, and/or muscle 
protein synthesis rates throughout the aging process [122-125]. 
 The delivery of oxygen and fuel to muscle tissue is dependent upon a vast 
capillary network.  This intricate delivery system can be significantly altered due to 
partial occlusion of vessels by atherosclerotic plaque and defects in arterial compliance. 
Other age associated conditions such as hypertension can reduce blood flow and 
compromise oxygen delivery.  In 1997, the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure reported that Hypertension 
occurs in more than two thirds of those over age 65 [126].  Subsequent reviews have 
shed further light onto these reported relationships [127,128].  Such noted changes are 
more common in the elderly, and can measurably impact protein synthesis and 
mitochondrial function, but the degree of these effects merits further study [98].      
 The progressive loss of innervations, motor neurons, muscle stimulation, and 
declining neurological function as we age play crucial roles in age-related muscle 
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dysfunction and atrophy [129-132].  Muscle denervation leads to atrophy, the result of 
which can result in decreases of muscle mass to less than one half its original weight 
within a month [98].  Tomlinson and Irving [133] studied motor neuron quantification in 
the entire lumbo-sacral spinal cord of 47 individuals aged 13-95.  After the age of 60, 
there was as much as a 50% loss of neurons in the elderly compared to younger or 
middle aged subjects.    
There is an abundance of research supporting the idea that older people have 
“trainable” physiology, and that they would reap many health benefits from exercise.  It 
is currently felt that prevention of age-related muscle loss is the key to healthy aging. 
Exercise research has shown the greatest promise for both prevention and treatment of 
sarcopenia.  Ades, et. al. looked at a group of community dwelling men and women over 
the age of 65.  Participants were randomized to either a weight-training or no training 
program for 3 months.  The intervention group showed significant improvements in both 
leg strength and walking endurance [134].  Resistance training has also been shown to be 
effective in the elderly.  An earlier study looked at nursing home residents with an 
average age of 87 [135].  The participants underwent a 10-week resistance training and 
nutritional intervention, showing gains in strength, improving by 125% compared to less 
than a 3% change in the control group.  Other benefits included improved gait velocity, 
stair-climbing power and spontaneous physical activity.  Through training adaptation, 
muscle physiology is enhanced via increases in muscle fiber size and muscle protein 
synthesis in response to resistance training [99,105,136,137].  Increases have also been 
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shown to occur in specific muscle proteins such as myosin heavy chain, which some [99] 
considered to be the key contractile protein.         
In consideration of these findings, it seems apparent that the process of 
sarcopenia is complex, and is likely to have a profound impact on numerous body 
systems as the aging process progresses.  Although it has yet to be specifically proven 
that there is a clear cause and effect relationship between muscle mass loss and such 
physiological changes, it stands to reason that reduced synthesis rates of specific muscle 
proteins, mitochondrial dysfunction, poor nutrition, reduced anabolic hormone levels, 
alterations in perfusion, altered neurological function, and reduced physical activity 
could all be reasonably connected to losses in muscle strength, mass and function.  In 
order to offset these losses, potentially slow the aging process, and maximize functional 
capacity throughout the aging process, further interventions in the areas of exercise, 
nutrition and preventive health are inevitable. 
Exercise Recommendations 
 The current guidelines by the CDC and the American College of Sports Medicine 
(ACSM) recommend 30 minutes per day on most days of the week.  Research has shown 
that these guidelines allow men and women to experience decreased rates of 
cardiovascular disease and premature mortality [138].  The NIH has done extensive 
research in the area of exercise intervention in promoting health and established the 
following guidelines.  Weight loss is recommended to lower elevated blood pressure in 
overweight and obese persons with high blood pressure.  Exercise is also strongly 
recommended to lower elevated levels of total cholesterol, LDL-cholesterol and 
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triglycerides and to raise low levels of HDL-cholesterol in overweight and obese persons 
with dyslipidemia [77].   If weight loss is achieved it can lower elevated blood glucose 
levels in overweight and obese persons with type 2 diabetes.  The combination of a 
reduced calorie diet and increased physical activity is recommended, since it produces 
weight loss, decreases abdominal fat, and increases cardiorespiratory fitness [77].   
 Due to research supporting that older women are higher risk in regards to 
inactivity, obesity and fall risk, innovative programs are needed to meet the needs of this 
population.  Curves International has had an overwhelming response by those who 
would not ordinarily frequent a gym or workout center as evidenced by the 10,000 
centers world-wide.  The 30 minute circuit and nutrition plans are offered in a women’s 
only environment that allows the female population to feel less intimidated in pursuing 
weight loss and a higher level of fitness.  This environment also allows for socialization 
and accountability by their peers and work out supervisors.  Members of the Curves 
International clubs are able to provide support to each other in a non-intimidating setting 
that has the added benefit of work out attendants providing support, encouragement and 
assistance with machine use and technique.  Extensive & ongoing research supports the 
effectiveness of the Curves program in positively affecting women’s health and fitness 
[64,139-141]. 
 Barring any medical contraindications, cardiovascular fitness may be addressed 
at any age.  Another advantage of consistent exercise is the ability to prevent and/or 
reduce declines in functional ability that is often viewed as normal aging [4].  The 
positive effects of exercise help offset conditions that the general public views as 
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inevitable during the aging process.  Some of these conditions include improved bone 
health with subsequent reduction in risk of osteoporosis, improved postural stability, 
reducing the risk of falling and possible fracture, as well as increased flexibility and 
range of motion.   
 It has been established that weight loss in obese older populations can improve 
functional fitness, overall health and independence.  The cardiovascular system is one 
critical body system that steadily decline with age.  For example, VO2 max declines 
approximately 30% between the ages of 20-65.  The greatest rate of VO2 decline 
reportedly occurs after the age of 40 [142].  One area in the elderly that contributes 
significantly to VO2 levels is decreased muscle mass.  The loss of muscle mass and 
subsequent strength can profoundly affect the quality of life in the elderly.  The lack of 
muscular support can affect stability, functional capacity for activities of daily living and 
metabolism.  All of these factors can cause and/or exacerbate obesity [142].  In research 
done in younger age groups utilizing the Curves circuit and nutrition plans, it has been 
shown that cardiovascular benefit and maintenance of muscle mass during weight loss 
are obtainable [140]. 
Metabolic Disorders & Obesity 
 According to recent estimates, over 50 million and perhaps 75 million Americans 
meet criteria for metabolic syndrome [143].   The criteria include: abdominal obesity 
(waist size > 40 inch in men or > 35 inches in women), triglycerides ≥ 150 mg/dL, HDL 
< 40 mg/dL in men or < 50 mg/dL in women, systemic hypertension (BP > 130/85 mm 
Hg), and fasting blood glucose > 110 mg/dL.   It is also current knowledge that weight 
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loss decreases diastolic blood pressure and serum LDL cholesterol, triglycerides, insulin, 
glucose and increases HDL cholesterol [143]. 
 Based on the defining characteristics noted above in diagnosing Metabolic 
Syndrome, waist-hip ratio (WHR) measures and waist circumference (WC) play an 
integral part in assessing risk for metabolic disorders and have been proven to be a better 
indicator of cardiovascular risk.  Schneider et al. (2006) looked at whether WHR or WC 
are more sensitive measures for visceral obesity, and which measure may be more 
indicative of cardiovascular risk.  This group of researchers studied 5,377 unselected 
subjects (2,016 men and 3,361women) without arteriosclerotic disease, aged 20-79 years 
from the DETECT (a cross-sectional, clinical-epidemiological study) laboratory sample 
in a primary care setting.  The intervention included measuring anthropometric 
parameters and assessing CHD risk by clinical exam, patient history, and a standardized 
laboratory program.  The associations of BMI< WC, hip circumference, WHR and 
waist-to-height ratio (WHtR) to cardiovascular risk by calculating the area under the 
receiver-operating characteristics (ROC) curve in combination with adjusted odds ratio 
for metabolic syndrome, dyslipidemia and type 2 Diabetes.  Their results showed the 
area under the ROC curve for WHtR was significantly higher than for all other 
anthropometric parameters with respect to all risk conditions in women and to 
dyslipidemia and Diabetes Type II in comparison to men.  The odds ratio for presence of 
risk conditions with one standard deviation increase of each anthropometric parameter 
was highest for WHtR or WC.  They concluded that there are some indications that 
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WHtR or WC may predict prevalent cardiovascular risk better than BMI or WHR 
despite the small differences noted in this study [144].   
 Some researchers have tested whether both BMI & WHR may be a better 
determinant of cardiovascular risk than either separately.  Zhu et al. (2004) put this 
theory to the test by combining waist circumference (WC) and BMI in evaluating 8,712 
white men and women from the Third National Health and Nutrition Examination 
Survey.  The optimal combination of BMI and WC using current cut-off points was also 
examined.  Specificity, sensitivity, and receiver operating characteristics curves were 
compared between the combined measures and BMI alone.  The results showed that for 
white men, the optimal combination of BMI and WC for the identifying CHD risk 
factors was 0.68 x BMI  + 0.32 x WC.  This combination generated a score that better 
estimated the odds of having CHD risk factors than either alone.  For white women, WC 
alone largely determined the likelihood of having CHD risk.  Combined measures 
showed a higher sensitivity or a shorter distance in receiver operating characteristic 
curves in the identification of CHD risk factors.  Reported conclusions support 
combining measures of BMI and WC so a higher overall test performance for CHD risk 
factors may be utilized in some ethnic groups as an improved screening tool [145].    
 Despite the means of measure, it is well known & widely accepted that obesity is 
a major risk factor for the development of chronic diseases and mortality [146,147].  The 
risk of CHD increases with increased BMI [147].  There have also been several 
prospective studies that have shown that increased abdominal fat accumulation is an 
independent risk factor for type 2 diabetes mellitus as well as cardiovascular risk 
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conditions such as CHD, stroke and hypertension [148-151].  The accumulation of 
visceral fat is associated with increased free fatty acid (FFA) secretion, 
hyperinsulinemia, insulin resistance, hypertension and dyslipidemia [152,153].   
Since Gerald Reavins established the diagnosis of Syndrome X in 1988 (currently 
metabolic syndrome) there have been new insights shed in the manifestations of this 
disorder.  Insulin resistance once thought of as one of four components of Metabolic 
Syndrome is now thought to be the single dominant factor predicting this pathology 
[154-156].  Insulin resistance occurs at the cell membrane and is an early indicator of 
disease. 
Serum Markers 
 The physiological effects from obesity can affect the entire body system.  The 
deposition of intra-abdominal fat and sarcopenic obesity can alter metabolic pathways 
and lead to excess energy (fat) redirected towards peripheral organs.  The excess lipids 
can also enter non-oxidative pathways resulting in production of toxic, reactive lipid 
species [157].  This process can lead to lipotoxicity induced apoptosis.  The 
accumulation of these reactive lipids can be found in organs such as the liver and heart.  
The alterations in metabolism and fat deposition play a major role in the development of 
comorbidities of obesity which include:  coronary artery disease, stroke, type 2 diabetes, 
hypertension, dyslipidemia, musculoskeletal disorders, some cancers and deep vein 
thrombosis [157].  There are also hormonal mechanisms associated with obesity that 
include abnormal alterations in leptin, ghrelin, insulin and/or adiponectin.   
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 Insulin, one of the most powerful hormones produced by the body is a major 
regulator of glucose metabolism.  One primary regulator of basal insulin secretion 
between meals is the presence of fatty acids [158].  In obesity, there is an overabundance 
of free fatty acids secreted from a large reservoir of adipose tissue.  The fatty acid 
regulation of basal insulin secretion between meals serves as a significant determinant of 
whole body “insulin sensitivity”.  Persistent elevation of free fatty acid levels has direct 
effects on metabolism in muscle and liver, dampening the effect of insulin [159-162].  
The continued process of adipocyte hypertrophy (e.g., fat mass) produces an oversupply 
of fatty acids in the blood that contribute to metabolic disturbances via many pathways 
in the obese [163].  Sustained elevated levels of insulin, despite the cause, typically leads 
to generalized insulin resistance [163].  In transgenic mice, hyperinsulinemia caused 
insulin resistance, reduced insulin-receptor binding as well as increased triglycerides 
[163].  These findings support the idea that hypersecretion of insulin can be a cause, and 
the result of insulin resistance [163].   
 The presence of cytokines adds to the complex state of obesity [164-168].  TNF-
α can produce insulin resistance at the level of target cells for insulin [163].  In research 
on obese mice, the insulin resistance of macrophages is associated with hypersecretion 
of cytokines and the enhanced density of macrophages found in fat depots bolsters the 
idea that cytokines play a major role in insulin resistance [163].  Despite the complexity 
of insulin resistance and cell signaling, one key intervention in treating the obese patient 
remains to be moderate caloric restriction, moderate exercise, 5%-10% weight loss and 
treatment of co-morbid conditions associated with obesity [163].       
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 Adipose tissue has been referred to as one of the largest endocrine organs, having 
paracrine, autocrine and endocrine function [157].  Its effects on the body system have 
also been shown to differ by location.  Adipose tissue plays a role in regulating body 
weight.  It secretes products such as leptin, adiponectin, interluekin-6, TNFα, 
angiotensinogen, plasminogen activator-inhibitor 1 (PAI-1), adipsin (complement factor 
D), sex steroids, and glucocorticoids.  Many of these products have been present in the 
literature since the mid-1990s but were not always connected to obesity [169].  These 
hormones play an intricate role in the etiology of obesity.  Leptin, a cytokine-like 
polypeptide, can have an effect on long-term control of energy intake, whereas ghrelin 
and insulin appear to have short-term impact on energy intake [169].  Insulin, an 
anabolic hormone, has the known function of direct storage and utilization of energy in 
adipocytes.  In obesity, insulin is often in abundance in the body.  Insulin is often found 
in high amounts due to the lack of communication between insulin and its receptor 
located on the cell membrane.  Insulin secretion subsequently increases by the beta cells 
of the pancreas [169].   
 Abdominal obesity and Type II Diabetes have proven to be related to insulin 
resistance.  Leptin and adiponectin have also been shown to play a role in insulin 
regulation.  They both have been linked to increase insulin sensitivity and leptin has 
been shown to decrease insulin secretion.  Leptin and other anorectic (pertaining to 
anorexia) cytokines may also mediate levels of ghrelin.  Ghrelin is found in high 
concentrations in the stomach and its expression and secretion increases with fasting.  
This area of research shows a lot of promise in better understanding the pathophysiology 
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of obesity on a cellular level [169].Adiponectin, a protein secreted by adipose tissue, is 
present at lower levels in the obese.  It has been shown to affect different aspect of the 
immune system and subsequent inflammatory responses.  Low levels of adiponectin 
have been associated with cardiovascular disease, diabetes and insulin resistance [169].  
Hyperlipidemia, defined as abnormal lipid levels is a known risk factor for Coronary 
Heart Disease (CHD).  In particular, concentrations of total cholesterol and low-density 
lipoprotein (LDL) cholesterol have been highly correlated with CHD.  Low levels of 
High density Lipoprotein (HDL) are an individual risk factor for CHD.  Elevated 
triglycerides are also associated with CHD and often co-exist in those with low HDL and 
high LDL.  Triglycerides also respond very well to non-drug therapy.  Pharmaceutical 
companies track prescription compliance of statin therapy and have noted that 
approximately 30% of patients initiated on statins do not continue their prescriptions 
[170].   
Due to the financial burden of these drugs, many patients admit to taking their 
medicine every other day, or a few times a week to decrease cost.  Outcome studies on 
statin therapy base results on daily compliance.  Recent literature also suggests that 
abrupt stoppage of this medication may be more harmful than if therapy had never been 
initiated.  In the elderly population, it is often debated whether long term statin therapy 
benefits out way the risks.  These drugs are financially taxing and can cause unpleasant 
symptoms as well as negative side effects in muscle and liver tissue.  Due to the multi-
system benefits of exercise, this population stands to reap tremendous benefit from 
lifestyle modification.   
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 Fahlman et.al (2002) examined the relationship between exercise and plasma 
lipoprotein levels in the elderly population.  The purpose of the study was examining the 
effects of endurance and resistance exercise on plasma lipoprotein levels in elderly 
women who were active but non- exercising prior to the study.  The total number of 
participants equaled 45 healthy, active women, aged 70-87 years, randomly assigned to 
either an aerobic training (AT, n=15), resistance training (RT, n=15) or control (C, 
n=15).  The AT group walked three days a week at 70% heart rate reserve.  The duration 
on day one was 20 minutes, and the time increased by five minutes each day until 
participants were walking a total of 50 minutes per session (week 3) [171].  The training 
session for the RT group consisted of one to three sets of an eight repetition maximum.  
The C group maintained their normal routine.  Weight and diet were unchanged across 
groups.  The interventions lasted a total of ten weeks, while serum blood samples were 
obtained at week zero and eleven.  The AT training group had significant decrease in 1-
mile walk times and heart rate at completion of the walk and there was a significant 
increase in eight repetition maximum of all RT exercises.  Both the AT and RT groups 
experienced increased HDL cholesterol and decreased triglycerides at week 11 in 
comparison to week 0.  There were no positive changes in lipoproteins for the control 
group.  Both triglycerides and the total cholesterol to HDL ratio increased significantly 
while total cholesterol, HDL cholesterol and LDL cholesterol remained unchanged.  The 
RT group also had significant lower LDL cholesterol and total cholesterol compared 
with controls at week 11.  Both resistance and endurance training resulted in favorable 
changes to plasma lipoprotein levels for elderly women in only ten weeks.  These 
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changes occurred without changes in weight or diet.  The researchers concluded that 
high-intensity exercise alone can be used to modify lipoproteins in healthy elderly 
women [171].  Likewise, positive results have been reported comparing resistance 
training & multi-component exercise (ME), with ME yielding the better results in a 
similar population [172]. 
Protein Synthesis 
 Fractional synthesis rate (FSR) has been established as the preferred measure of 
protein synthesis, and measures the rate of tracer incorporation from the muscle 
intracellular free (MIF) pool into the protein-bound amino acid pool (PBAAP) 
[173,174].  The free amino acid pool (FAP) in muscle is often used as an acceptable 
surrogate of the precursor for muscle protein synthesis[174,175].  Control of the 
processes surrounding protein synthesis in tissue of free living humans is a complex 
process requiring continuous integration of multiple positive and negative stimuli [176].   
 Hypertrophy of skeletal muscle tissue following resistance exercise and the 
associated increase in protein synthesis is mediated by a synergistic interaction of 
mechanical, hormonal, and nutritional stimulation [16].  Mechanical and nutritional 
stimuli converge on cell signaling pathways that are under the influence of anabolic 
hormones and growth factors such as insulin and insulin-like growth factor 1 (IGF-1), 
resulting in increases in both global (e.g. cap-dependent) and specific (e.g. 5’ TOP) 
mRNA translation [15].  Consideration of the impact of transduction at the cellular and 
molecular levels on protein synthesis, in response to various types of stimuli (such as 
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mechanical, hormonal, and nutrient signals), may enhance our understanding of basic 
muscle physiology.   
 Enhanced understanding of these principles can be pursued through their 
application in post-resistance exercise nutrition strategies.  Such strategies seek to 
optimize the anabolic hormonal response of resistance exercise through ingestion of 
macronutrients [177].  Feeding a complex diet of macronutrients results in increased 
blood concentrations of insulin and amino acids, which is associated with insulin-
dependent and insulin-independent stimulation of protein synthesis.  Conversely, a 
decrease in plasma insulin and amino acid levels in the blood is observed upon reversal 
of the effects of the feeding, with protein synthesis machinery assembly returning to pre-
prandial levels [178].  It has been reported that as muscles age they become increasingly 
resistant to the anabolic effects of amino acids [179-181].  Specifically, feeding 
(hyperaminoacidemia) has been reported to double muscle protein FSR [35,182,183].  
However, potentially less favorable results have been suggested in elderly populations 
[184].  These data support the plausible importance of addressing this concern during the 
earliest stages of the aging process. 
 Hypertrophy of skeletal muscle is defined as an increase in myofiber diameter, 
and is characterized by increased contractile force and augmented protein synthesis [15].  
Protein synthesis is comprised of three phases: initiation, elongation, and termination.  
Initiation of messenger RNA (mRNA) translation is a key site of regulation for gene 
expression and protein biosynthesis in skeletal muscle tissue [185,186].  Mitogens (e.g. 
insulin and IGF-1) and nutrients (e.g. amino acids) converge on cell signal transduction 
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pathways to affect translation initiation [187].  Nutritional signals control gene 
expression through modulation of cell transduction pathways that have traditionally been 
thought to be stimulated by the action of hormones [188].  For example, the distinct 
signals from insulin, amino acids, and resistance exercise reportedly converge on the 
(phosphoinositide 3-kinases) PI3K – (protein family also called protein kinases B) 
Akt/PKB – (mammalian target of rapamycin) mTOR signaling pathway to promote 
muscle hypertrophy following resistance exercise [187].  Hence, the overall molecular 
detection of protein synthesis may not be best marked by select protein up-regulation.  
Rather, a coordinated response from multiple points in the signal transduction pathways 
is essential for complete understanding of the process of mRNA translation associated 
with muscle hypertrophy [187]. 
 Branched chain amino acid mediated increases in protein synthesis are attributed 
to regulation at the initiation phase of translation [189].  Immediately following 
resistance exercise and without supplementation, 4E-BP1 (eIF4E-binding proteins) 
phosphorylation is significantly reduced [20].  However, recent findings in the ESNL 
have suggested that it may be significantly increased at two hours post-exercise when 
BCAA and LEU supplementation is ingested before and after exercise [190].  While 
BCAA (and especially LEU) modulate specific and global mRNA translation through a 
mitogen (a chemical substance that encourages initiation of cell division)-independent 
mTOR mechanism, they appear to modulate signaling through the pathway that is shared 
by the action of mitogens (e.g. insulin), rather than to directly regulate translation 
initiation [190].  Apparently there is a synergy between BCAA and the insulin effects on 
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the PI3K-Akt/PKB-mTOR signaling pathway, whereby optimized translation initiation 
may require a combination of amino acids and insulin [185,188,191,192].   
 Considering that the protein synthetic pathway is sensitive to the availability of 
both nutrients and hormones to modulate the initiation of mRNA translation, current 
literature suggests that the provision of carbohydrate (CHO) with amino acids may best 
elicit a coordinated mitogenic (e.g. insulin) and nutrient (e.g. amino acids) effect on both 
global and specific protein synthesis initiation markers [190].  Miller, et. al. (2003) 
demonstrated that a combination of amino acids and CHO consumed immediately before 
and one hour after an acute resistance exercise bout resulted in a significantly greater 
skeletal muscle protein synthesis as compared to either separately, as determined by 
stable isotope methodology [193].  The enzymes Akt, mTOR, p70(S6K), rpS6, GSK3, 
and glycogen synthase interact in the control of protein and/or glycogen synthesis in 
skeletal muscle, and each has been found to respond to exercise and nutrient 
supplementation.   
 Ivy (2008) investigated whether nutrient supplementation post exercise, in the 
form of a carbohydrate-protein (CHO-PRO) supplement, would alter the 
phosphorylation state of these enzymes in a manner that should increase muscle protein 
and glycogen synthesis above that produced by exercise alone.  After a 45 min cycling 
session followed by sprints, and again 15 min later, 8 subjects (well-conditioned males, 
who were 23.6 ± 1.2 years of age) ingested 400 ml of a CHO-PRO drink (7.8% dextrose 
and 1.8% protein-electrolyte) or a placebo drink.  At 45 min after supplementation, 
CHO-PRO treatment yielded greater phosphorylation of Akt (65%), mTOR (86%), rpS6 
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(85-fold), and GSK3alpha/beta (57%) than pre-exercise levels.  Although p70(S6k) 
showed an exercise response after 45 min, there were no differences between treatments.  
Glycogen synthase (GS) phosphorylation was significantly reduced 45 min after exercise 
for both treatments, but the reduction in phosphorylation was greatest during the CHO-
PRO treatment (3-fold decrease).  Thus, indicating greater activation of GS following 
supplementation.  No difference between treatments was detected prior to exercise for 
any of the enzymes [194].  These results suggest that a post exercise CHO-PRO 
supplement alters the phosphorylation levels of the enzymes tested in a manner that 
should accelerate muscle glycogen synthesis and protein initiation during recovery from 
cycling exercise. 
 More practically, a 2006 study compared dietary protein intake along with post-
exercise supplementation.  Reported conclusions suggested that post-exercise 
supplementation may have a more direct impact on favorable FFM profiles than a simple 
increase in daily dietary protein support [51].  Cumulatively, these data seem to support 
the use of a combined PRO and CHO supplement in the post-exercise recovery period to 
activate enzymes associated with muscle protein synthesis via insulin-mediated PI3K-
mTOR pathways.  Emerging data in the literature suggest that a combined CHO - PRO 
[perhaps more specifically select amino acid(s)] supplement stimulates protein 
translation [197] through mTOR activation [195].  
 Direct measurement of muscle protein synthesis can provide relevant information 
regarding the metabolic state of the tissue, and therefore, should be included as an 
outcome variable when examining anabolic/catabolic conditions.  As suggested 
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previously[196], direct incorporation methods using tracers such as [13C]leucine or 
[13C]-, [15N]-, or [2H]phenylalnine have traditionally been used to measure tissue specific 
protein synthesis and are generally accepted for providing reliable measurements.  
Briefly, by providing a known amount of labeled (tracer) and unlabeled amino acid 
(tracee) the tracer and tracee will mix with the endogenous pool and become 
incorporated into protein over time. The tracer and tracee are generally administered as a 
primed-constant infusion (a priming bolus of tracer and tracee is administered and is 
continuously provided at a lower concentration to maintain enrichment), or as a flooding 
dose (a supraphysiological bolus of tracer and tracee is provided over seconds to 
minutes). Protein synthesis can be determined by measuring the enrichment 
(tracer/tracee) of the protein against the enrichment of the precursor (i.e., precursor: 
product labeling ratios). However, two central concerns that have existed with the 
precursor-product method have been identification and measurement of the true 
precursor (aminoacyl-tRNA), and the inability to conduct the tracer experiments in a 
free-living environment over an extended period of time, an integrative/cumulative 
assessment.  Specifics with regard to these concerns have been addressed previously in 
the literature [196], and investigators have proposed various methods by which they may 
be addressed [38,39,175,196-198].   
 Currently, a more convenient but less familiar approach has come into favor 
which allows for circumvention of these noted limitations.  The use of 2H2O as proposed 
in this paper was first described [199], re-investigated [200], and has been used more 
recently in studies at Texas A&M[196].  In this recently published study by Gasier, et. 
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al., the effect of a high-intensity bout of resistance exercise in the fed state with energy 
and macronutrients controlled over 24 h in humans was examined. Although no 
stimulatory effect of exercise on FSR in the mixed vastus lateralis was observed, there 
was a significant effect on the myofibrillar FSR with exercise. 
Deuterium (2H) & Heavy Water ( 2H2O) 
 Deuterium [heavy hydrogen, (2H)]:  The adult human body naturally contains 
deuterium equivalent to the amount in about 5 grams of heavy water, and comparable 
doses of heavy water are still used as safe non-radioactive tracers for metabolic 
experiments in humans and other animals.  Because it would take a very large amount of 
heavy water to replace 25% to 50% of a human being's body water (which in turn is 70% 
of body weight) with heavy water, accidental or intentional poisoning with heavy water 
is unlikely to the point of practical disregard, and cannot be considered toxic to humans 
[201].  It has been estimated that a 70 kg person might drink 4.8 liters of heavy water 
without serious consequences.  For example, a 70 kg human containing 50 kg of water 
and drinking 3 liters of pure heavy water per day, would take almost 5 days to reach 
25% deuteration and about 11 days to approach 50% deuteration.  Thus, it would take a 
week of drinking nothing but pure heavy water for a human to begin to feel ill, and 10 
days to 2 weeks (depending on water intake) for severe poisoning and death.  The U.S. 
issued a patent for the use of heavy water to treat hypertension (high blood pressure).  
Reportedly, decreased blood pressure may partially explain reported incidents of 
dizziness upon ingestion of relatively larger amounts.  Small doses of heavy water (a few 
grams in humans, containing an amount of deuterium comparable to that normally 
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present in the body) are routinely used as harmless metabolic tracers in humans and 
animals [202]. 
 Typically, dosages are in the range of 40 mg per kg of 2H2O [203].  These values 
are derived from considerations of instrumental accuracy at the end of the test period, 
when as little as 10% of the isotope remains in the body water.  Using this dosing 
regime, FSR can be measured with a coefficient of variation of better than 5%.  
Recently, it was proposed that much smaller dosages might be effective [207].  
However, considerable care in experimental design would be required for this to be done 
without severely prejudicing the quality of the results [204,205].   
 Deuterium oxide (2H2O), has been used successfully to measure protein synthesis 
in mice, rats and humans[199,206-211].  Studies have shown that by administering a 
dose of 2H2O rapid equilibration (~ 20 min) of the tracer in body water will 
occur[209,212] and both rapid and extensive labeling of intracellular amino acids (e.g. 
alanine) primarily via transamination[199,213], which can then become incorporated 
into protein.  Reportedly, since alanine is readily produced intracellularly and has four 
possible sites for 2H-labeling[213], its labeling should reflect that of body water over a 
wide variety of conditions [206,209,212].  Additionally, maintaining a steady 
concentration of 2H2O in body water (thus 2H-labeled alanine) over days to weeks by 
providing periodic maintenance dosages of 2H2O in drinking water is relatively practical 
[199,206,208,209], albeit admittedly somewhat expensive.  Finally, 2H-labeling of 
alanine does not appear to be influenced by common metabolic activities such as 
feeding[209,210,212] and/or exercise[211].  Therefore, it stands to reason that non-
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steady-state protein metabolism may be assessed over short and long periods of time, 
providing a free living account of what is actually occurring within selected tissues of 
interest. 
 Previously, cumulative assessments of whole body protein synthesis have been 
made using oral [1-13C]lysine[214] or intravenous [1-13C]leucine [215].  However, few 
have examined skeletal muscle over extended periods.  The human rate of protein 
synthesis (RPS) has been estimated at 1.5-2% per day [216], but this is an estimation 
based on calculations collected over only up to a six hour period.  A recent study [196] 
comparing these more invasive tracer protocols to the use of deuterium oxide (2H2O) as 
a tracer methodology questioned such extrapolations, and suggests that the 2H2O 
methodology might produce more accurate results when measuring FSR over longer 
periods of time (e.g. 24 hours or longer) in free living environments.    
 2H2O has been reported to accurately, and relatively non-invasively, measure 
protein synthesis over short and long periods of time [207,208,210,212].  However, only 
recently has this methodology been investigated in reference to RE and feeding.  
Recently published observations[196,211] suggest that there may be differences between 
cumulative myofibrillar v. mixed muscle protein synthesis after an acute bout of high 
intensity RE.  However, studies have not investigated the effects of acute or subacute 
moderate intensity combined exercise (aerobic/anaerobic) with timed nutrient intake on 
protein synthesis in overweight post-menopausal women.  Studies have also not 
investigated the effects of a commercially available PRO/CHO supplementation (acutely 
or sub acutely) in such an untrained and/or trained population.  Neither have studies 
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investigated the effects of timed nutrient intake in overweight post-menopausal women 
over extended training periods utilizing the 2H2O stable isotope methodology. 
Nutrition 
 A key component of weight management is sound dietary strategies and a 
consistently well-balanced diet.  The appropriate percentage of macronutrients is also 
critical in balanced nutrition.  Recommendations should include increased fruits and 
vegetables, decrease fat content to < 30% with < 10% from saturated fat, lean protein 
sources, protein intake for older men and women is between 1.0-1.25 g of high quality 
protein and appropriate percentages of macronutrients [4].  This study will offer one 
nutrition plan (higher protein diet) with two variations: 1.) with, & 2.) without post-
exercise nutrient timing.   
 The problems of obtaining accurate assessments of dietary intake from free-
living subjects are well known [217], and doubly labeled water (DLW) has been used on 
many occasions to assess the performance of dietary assessment techniques [218].  The 
assumption is that for a subject in energy balance, total energy expenditure (TEE) and 
energy intake are equal; therefore, any difference between DLW results and declared 
energy intake must be due to inaccuracies in reporting [203].  Efforts at validation of 
dietary self-assessment and/or energy expenditure have been long pursued [219-223].  A 
recent publication has attempted to provide a framework for the validation of dietary 
self-assessment on this basis [222].  Small concentrations of heavy water are nontoxic.  
Dosages of the two isotopes of doubly labeled water DLW [2H (deuterium), and 18O 
(Oxygen-18)] equilibrate with total body water (TBW).   Oxygen-18 is a natural, stable 
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isotope of oxygen and one of the environmental isotopes.  Deuterium (2H) leaves the 
body as water (H2O), while 18O leaves as water and carbon dioxide (CO2), two elements 
common to normal human metabolism and respiration [224]. 
 Successful aging involves the ability to maintain three key behaviors: decreased 
risk for disease and related disability, high mental and physical function, and active 
participation in life [225].  Nutrition is considered one of the major determinants in this 
process.  Nutritional choices are not only critical to physiological well-being, but also 
contribute to social, cultural and psychological quality of life.  The most influential 
behaviors influencing aging aside from genetics include consistently eating a healthy 
diet, being physically active, and avoiding tobacco [225].      
  Normal aging is accelerated by variables that are associated with the 
concomitant frailty of aging.  Aging adults experience age-related declines in food intake 
as well as other complicating factors in achieving adequate nutrition such as poor 
dentition, financial resources and alterations in brain function that can all contribute to 
poor nutrition.  One such factor, the decline in food intake has been termed the anorexia 
of aging.  Many experts in the field of gerontology consider the decline in food intake to 
be an important factor in the development and progression of sarcopenia [97].  Normal 
aging in humans progressively leads to the decline in neuromuscular function, ultimately 
affecting the ability to perform daily activities.  Sarcopenia has also been coupled with 
the condition of obesity (sarcopenic obesity).  This combination of conditions obviously 
compounds the concerns for the elderly.   
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 As we age, many variables (e.g. financial constraints and access to food options) 
can and do affect sound nutritional habits.  Extensive research has been conducted to 
compare various macronutrient combinations for health, weight reduction and 
maintenance in aging populations.  Two areas that have received considerable attention 
include higher protein/lower carbohydrate and “normal” carbohydrate/lower protein 
diets.  The Curves program offers both of these options.  Previous Curves research has 
yielded positive results with both diets during a 14 week intervention including exercise 
[139].   
 Previously cited research has suggested that inadequate protein intake most likely 
plays a key role in the complex equation of sarcopenic obesity.  It is well accepted that 
adequate protein intake is crucial in maintaining cellular integrity, function, and health 
by contributing amino acids that serve as precursors for essential molecules which serve 
as building blocks for all cell components [226].  It is also important to note that 
adequate intake of carbohydrates, fats, vitamins, minerals; fiber and water also need to 
be ingested in order for these processes to occur.  High protein diets have also shown 
improvement in weight loss, maintaining muscle mass and improving blood markers in 
all ages.  There is also a substantial amount of research that supports certain diagnoses 
may actually respond more favorably to high protein nutrition plans. The majority of 
nutritional research in weight loss and maintenance has been done on the adult 
population spanning from young adult (age 20) to the young old (aged 60).  There is 
perhaps, a relative shortage of research in the healthy elderly.  Nutritional research in 
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this age group appears to be disease specific, and primarily focused on institutionalized 
or hospitalized patients.   
 Noakes et.al. performed a study comparing hypocaloric high protein (HP) diet to 
a high carbohydrate (HC) diet [142].  Approximately 100 participants with a body mass 
index of 32 ± 6 and age of 49 ± 9 years completed the study.  They were randomly 
assigned to one of two isocaloric 1,337 kilocalorie (5600 kJ) dietary interventions for 
twelve weeks according to parallel design.  Weight loss achieved was 7.3 ± 0.3 kg with 
both diets.  The participants with high triacyglycerol lost more fat mass with the HP diet 
than with the HC diet (SEM= 6.4 ± .7 and 3.4 ± .7 kg, respectively) and had a greater 
decrease in triacyglycerol concentrations with the HP (~5.9 ± 0.19 mmol/L) that with the 
HC (~0.03 ± 0.04 mmol/L) diet.  Fasting LDL-cholesterol, glucose, insulin, free fatty 
acid, and C-reactive protein concentrations decreased with weight loss.  Serum vitamin 
B-12 increased 9% with both diets; homocysteine did not change significantly.  Bone 
turnover markers increased 8-12% and calcium excretion decreased by 0.8 mmol/d.  
Creatinine clearance decreased from 82 ± 3.3 to 75 ± 3.0 mL/min.  This research 
suggested the HP diet was effective in producing weight loss as well as improving risk 
factors for diabetes and heart disease.        
 Meckling, et.al. (2004) studied a population of adult overweight and obese men 
and women (age 24-61) to compare the effects of a low-fat (LF) diet versus a low-
carbohydrate (LC) diet.  The participants in the LF diet consumed approximately 17.8% 
of energy from fat, compared with their habitual intake of 36.4% and had a resulting 
energy restriction of 606 kcal/day (2540 kJ/d).  Participants on the LC diet consumed an 
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average of 15.4% carbohydrate, compared with habitual intakes of about 50% 
carbohydrate, and had a resulting energy restriction of 763 kcal (3195 kJ/d).  Significant 
weight loss was reported in both groups over the ten week intervention, and there were 
almost identical improvements in body weight and fat mass.   
 In the Meckling study, LF participants were reported to have lost an average of 
15 pounds (6.8 kg) with a decrease in body mass index of 2.2 kg/m2, compared with a 
loss of 7.0 kg and a decrease in body mass index of 2.1 kg/m2 in the LC participants.  
The LF group showed a better preserved lean body mass when compared with the LC 
group.  However, the LC group showed a significant decrease in circulating insulin 
concentrations.  Reported group results indicated the diets were equally effective in 
reducing systolic blood pressure by about 10 mmHg and diastolic pressure by 5 mmHg.  
Blood β hydroxbutyrate (supporting adipose tissue utilization for energy) concentrations 
increased in the LC group only at the 2 and 4 week time points.  Data reported in this 
study suggest that energy restriction achieved by the LC diet is equally effective as the 
LF diet strategy for weight loss and decreasing body fat in overweight and obese adults 
[227].   
 Other benefits noted in literature for low carb/high protein diets include: 
decreased central adiposity and reduction in cardiovascular disease rates [142].   Visceral 
adiposity is of concern because it is felt to be more threatening possibly due to its 
position in the body and drainage via venous portal veins.  It is important to note that 
long term studies need to be done in this area to confirm short duration studies.  It has 
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also been noted that low carbohydrate/high protein diets are not always well tolerated 
long term and safety in patients with altered renal function is unknown as well [142].   
Layman, et.al (2005) tested the benefits of high dietary protein, while maintaining the 
recommended macronutrient composition noted above.  Their study included forty-eight 
overweight and obese women (40-56 years) in two diet groups (with and without 
exercise).  The higher-protein, reduced-carbohydrate (PRO) diet was designed to provide 
dietary protein at 1.6 g/kg per day (~30% of calories) and ~ 30% of calories from dietary 
fat, allowing a carbohydrate-protein ratio of < 1:5.  The higher-carbohydrate, moderate-
protein (CHO) diet was designed to provide 0.8 g/kg per day of dietary protein (~15% of 
calories) and ~30% of calories from dietary fat, yielding a carbohydrate-protein ratio of 
>3:5.  Both of the diet groups were within the boundaries of Acceptable Macronutrient 
Distribution Ranges (AMDR) defined by the Institute of Medicine.  Each group was 
randomized into either supervised exercise or control, following the NIH guidelines of 
walking 30 minutes per day at least five days per week.  Conclusions were that diets 
higher in protein and moderate in carbohydrate appear to have advantages for weight 
reduction, body composition, and plasma triacylglycerol.  The high carbohydrate diet 
was shown to more efficiently decrease total and LDL cholesterol levels.  Hence, it was 
also concluded that diets should consider clinical outcomes and pre-existing lipid values 
[228].   
 Based on research to date, the high protein and normal carbohydrate diets both 
produce favorable weight loss in studies up to one year.  Evidence from some short term 
studies suggest that the high protein diet may offer more in regards to specific serum 
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markers (e.g., lipids) and blood pressure, but it has been suggested that it is unknown 
how tolerable these diets are over the long term.  There is also interest regarding the 
effects which low carbohydrate diets may have on phytochemical composition and fiber.  
Additionally, the long term safety of these diets ( > one year) in patients with altered 
renal function appears yet to be determined [142].  Longitudinal studies to test 
compliance and tolerance of diets, as well as long term effects in specific areas such as 
blood markers, bone density, muscle mass and ability to maintain weight loss are 
definitely of interest based on the reported studies.   
The purpose of the dietary intervention in this study is to compare results in a 
higher protein diet with & without timed nutrient intake in female participants of the 
Curves Fitness and Weight Management Plan. 
Nutrient Timing 
 A developing trend in research suggests that carbohydrate ingestion within 15 
minutes post-exercise helps to restore depleted glycogen reserves [49,59].  Intake of an 
adequate amount of carbohydrate within two hours of prolonged exercise is essential to 
resupplying/maintaining adequate glycogen stores for continued training.  Intakes with 
longer than a two hour delay are reported to result in 50 percent less muscle glycogen 
resupply.  The carbohydrate consumption stimulates insulin production, which in turn 
aids in the reestablishment of muscle glycogen levels.  However, the effect of 
carbohydrate consumption on glycogen storage does plateau.  Additionally, combining 
protein with carbohydrate in the two hour “window” after exercise nearly doubles the 
insulin response, which results in more stored glycogen [57].  Higher protein content, 
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however, has been suggested to have a negative impact because of slowed rehydration 
and glycogen replenishment [57].   
 Athletes who refuel with carbohydrate and protein are reported to obtain 100 
percent greater muscle glycogen stores than those who consume carbohydrate alone.  
Additionally, insulin is also highest in those who consume a carbohydrate and protein 
drink.  For resistance training, a ratio of 2:1 carbohydrate to protein has been shown to 
be most effective.  For long, strenuous endurance exercise, a 4:1 ratio of carbohydrate 
and protein seems to be a better choice. While solid foods may provide the required 
nutrients, a liquid may assimilate more rapidly, make it easier to achieve the preferred 
ratio, and thus more efficiently meet the 2-hour window.  It has been reported that the 
“anabolic phase” wherein the optimal effects of nutrient ingestion begins to deteriorate, 
or “close” within 45 minutes post exercise, and peaks within 15-30 minutes post exercise 
[229] (Figure 1).  The general premise is that by consuming critical nutrients [e.g. carbs, 
protein (specific amino acids), and vitamins] during a time sensitive window, one might 
spare muscle glycogen, achieve greater muscular endurance, stem the rise of the 
catabolic hormone cortisol (hence reducing muscle damage), and facilitate a more 
favorable environment for efficient recovery following exercise.  
 Consuming protein has other important uses after exercise.  Protein provides the 
amino acids necessary to rebuild damaged muscle tissue during intense, prolonged 
exercise.  It can also increase the absorption of water from the intestine, improve 
hydration status, and benefit the immune system.  A 2004 study reported that the 
administration of a carbohydrate beverage with additional protein calories showed 
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significant improvements in cycling time to fatigue, and reductions in post-exercise 
muscle damage (measured indirectly using plasma CPK levels) in comparison with a 
carbohydrate-only beverage [230].  Obese individuals eating a slightly higher protein 
diet (25% of calories from protein), lost significantly more weight and body fat than 
those eating a lower 
 
  Figure 1. Nutrient Timing Window (Adapted from Ivy & Portman, 2004). 
 
 
protein diet (12% of calories from protein) [231].  Prolonged strenuous exercise 
substantially depletes glycogen stores, which has important implications for post-
exercise nutrition.  Specifically, muscle glycogen replenishment is of the highest 
priority, and a carbohydrate/protein combination may play a major role in this process.  
Recent research has focused on the timing, amount, and type of carbohydrates, and the 
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ratio of protein to carbohydrates, in post-exercise meals.  One study suggests that an 
immediate intake, within 30-45 minutes following exercise, comprised of simple (high 
glycemic index) carbohydrates will stimulate both glucose transport and glycogen 
synthase activity, promoting faster muscle glycogen resynthesis[232].  Although 
prolonged strenuous exercise will not be the training design for this study group, it will 
be of interest to determine whether or not results indicate relative positive influences. 
 Perhaps most interestingly, a 2006 study suggested that post exercise intake may 
be more influential than total daily protein intake as an effective method for maintaining 
FFM during periods of either increased energy expenditure (e.g. exercise) or “marginal” 
protein intake [51].  Subjects of said study included (in addition to 22 men of the same 
age range) untrained (≤ 3 hours/wk) women (n=30, 60-69 years) who participated in a 12 
week moderate resistance exercise (RE) program.  The post exercise supplement 
consisted of a Boost HP beverage (Novartis/Mead Johnson) composed of 240 kcals (15 g 
protein, 33 g CHO, and 6 g fat per 8 oz.) or an alternate, presumably equivalent 
supplement (3 subjects who were intolerant of the Boost) given immediately post 
exercise in an amount corresponding to 0.4 g of protein/kg of FFM.  This approach 
seems particularly related to the type of routine proposed during our study.  Finally, the 
2006 study suggested that a randomized double-blind study would be necessary to 
confirm the reported results.  Although there are a plethora of studies supporting timed 
nutrition within a “window” surrounding exercise, a current study suggests that the 
timing period may be quite liberal depending on when the pre-workout meal was 
consumed[272]. 
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Conclusion 
 The aging population is currently one of the fastest growing segments in our 
nation [65] and lends itself to increasing investigational studies.  Due to the high 
prevalence of obesity in this age group, it has been estimated that almost one-third of 
health care expenditures is for older adults (over age 65) [66].  There is currently a 
limited amount of research in elderly nutrition intervention in non-institutionalized, 
healthy populations.  Hence, it has yet to be determined what the ideal macronutrient and 
caloric percentages are needed for this population.  Current literature supports that there 
are risks associated with weight loss in this age group.  There is debate surrounding ideal 
weight for this population due to potential harmful effects of weight loss on muscle and 
bone mass, as well as the ideal amount of weight loss necessary to produce optimal 
health.  Perhaps the best defense is a good offense.  If so, addressing these concerns 
early will offset some of the effects commonly observed in our aging population (an 
ounce of prevention).  This study will provide additional information regarding whether 
the current Curves HP diet, along with the addition of a timed nutrition option, is more 
or less effective in retaining muscle mass in overweight females as compared to the 
standard Higher Protein option.  A decline in muscle mass alters daily energy 
expenditure and insulin sensitivity as well as functionally related variables such as 
muscle weakness, fatigability and decline in endurance.  As a counter measure to the 
aging co-morbid conditions discussed in this paper, it stands to reason that an early 
preventive approach to deterrence would be advisable. 
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CHAPTER III 
METHODS 
Participants 
 
Approximately 20 sedentary, overweight female post-menopausal participants 
(50-70 years; BMI ~ 27+) participated in this 12 week prospective longitudinal clinical 
trial.  Participants were medically cleared by their physician in case any screening 
procedures (via ACSM guidelines) determine it a necessity, and were not allowed to 
participate if they had any uncontrolled metabolic disorder, or known electrolyte 
abnormalities; heart disease, arrhythmias, diabetes, or thyroid disease; a history of 
hypertension, hepatorenal, musculoskeletal, autoimmune, or neurological disease.  Nor 
were they accepted for participation if they were taking hypoglycemic, or androgenic 
medications; and/or, if they had taken ergogenic levels of nutritional supplements that 
may have affected muscle mass (e.g., creatine, HMB), anabolic/catabolic hormone levels 
(e.g., DHEA), or weight loss (e.g., thermogenics) within three months prior to beginning 
the study.  Exceptions were only allowed if the prospective participant had a medical 
condition, or history that the participant’s personal physician concluded was controlled, 
and therefore not be a limitation for participation in the study.  Participants that 
otherwise met eligibility criteria were informed of the study requirements, and signed 
consent statements in compliance with the Human Participants Guidelines of Texas 
A&M University and the American College of Sports Medicine.   
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Study Site 
All testing was conducted in the Exercise & Sport Nutrition Laboratory (ESNL) 
and the Human Countermeasures Laboratory (HCL), and sample processing conducted 
in the Muscle Biology Laboratory (MBL) Department Health and Kinesiology at Texas 
A&M University.  Exercise training will be conducted at the Curves circuit within the 
ESNL. 
Entry and Familiarization 
Participants who expressed interest in participating in this study were 
interviewed (screened) via phone to determine whether they qualified to participate.  
Those deemed to meet eligibility criteria were invited to attend an entry/familiarization 
session held within the ESNL.  Familiarization sessions were designed to provide detail 
as to requirements and expectations of the study.  During this session, participants signed 
Informed Consent Statements, and completed personal and medical histories; and were 
familiarized as to study protocol via a verbal (audiovisual) and written explanation 
outlining the study design, expectations, and implications.  The explanation included a 
description of the training and dietary program, and familiarization of the participants as 
to the tests which were to be performed.  Participants were required to obtain medical 
clearance from their personal physician prior to participating in baseline assessments.  
Those who qualified and accepted were scheduled for day 1 of T1 testing, after which 
they were matched and randomized, based on age and lean mass (LM), into either the I 
or D group.  Upon completion of day 1, they were scheduled for their second and third 
days of T1 testing. 
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Randomization 
 Participants were randomized into one of two groups based on age & LM.  The 
groups include: 1.) Immediate Timed Nutrition (I), and 2.)  Delayed Timed Nutrition 
(D).  Both groups were assigned the same higher protein diet, with the same balance of 
macronutrients and caloric content.  Both groups obtained a measured portion of their 
caloric and macronutrient content from the post exercise nutrition (shake) on days when 
they exercised & were tested (T1 & T4).   
Experimental Design 
Table 1 and Figure 2 (pg. 63, 64) outline the general research design and time 
course for the various assessments.  The independent variable is the timed nutrition.  The 
dependent variables are: FSR as measured via muscle biopsies; body composition [fat 
free mass (FFM), & fat mass (FM)], isotonic strength [Leg Press (LP) and Bench Press 
(BP)]; and resting energy expenditure (REE).   
Once medical clearance was obtained, participants were given an appointment 
for their T1 testing sessions as summarized in Table 1.  T1 was divided into 3 days of 
testing.  T1-Day 1 included of all standard ESNL resting and exercise procedures as 
outlined in Table 1, and described in detail later in this chapter.  T1-Day 2 was 7 days 
post T1-Day 1 to avoid any potential physiological implications from T1-Day 1, and to 
facilitate scheduling issues.  T1-Days 2 & 3 included 2H2O dosing, blood measures, 
biopsies, assigned meals (breakfast, lunch and dinner) as applicable according to the 
Curves high protein diet plan.  Participants completed their first exercise session on T1 
Day 2. 
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Table 1. Overview of Testing 
T-0 (Entry)           T-1    T-2/T-3                  T-4 
 Day 1  Day 1 
-Phone Interview 
-Familiarization 
-Assessment to  
  determine study 
  qualifications 
-General nutrition 
  Review 
 
 
REE; DEXA; BIA; 
Hip:Waist; Food/Activity 
Logs; Fasting Blood; 
QOL/Eating Satisfaction 
Surveys; Maximal 
GXT/ECG; 1 RM BP/LP; & 
Circuit Testing  
 
Participants randomized 
according to BMI and age  
into either the EARLY or 
LATE group 
REE; DEXA; 
BIA; 
Hip:Waist; 
Food/Activity 
Logs; Fasting 
Blood; 
QOL/Eating 
Satisfaction 
Surveys 
REE; DEXA; BIA; 
Hip:Waist; 
Food/Activity Logs; 
Fasting Blood; 
QOL/Eating Satisfaction 
Surveys; Maximal 
GXT/ECG; 1 RM BP/LP 
Day 21 
0600 Blood; 2H2O dose 
1 
0630 Curves Breakfast2 
08002H2O dose 2 
0830 Blood; Biopsy 1 
1000 Circuit Workout, 
1030  post exercise 
intake 
  (EARLY Group only) 
1045 Blood 
1100 Biopsy 2 
1230 post exercise 
intake 
   (LATE Group only) 
1300 Curves Lunch2 
13302H2O dose 3 
1515 Blood  
15302H2O dose 4 
1700 Curves Dinner2 
 
Day 31 
0545 Blood 
0600 Biopsy 3 
 
Day 21 
0600 Blood; 2H2O dose 1 
0630 Curves Breakfast2 
08002H2O dose 2 
0830 Blood; Biopsy 1 
1000 Circuit Workout, 
1030  post exercise 
intake 
  (EARLY Group only) 
1045 Blood 
1100 Biopsy 2 
1230 post exercise intake 
   (LATE Group only) 
1300 Curves Lunch2 
13302H2O dose 3 
1515 Blood  
15302H2O dose 4 
1700 Curves Dinner2 
 
Day 31 
0545 Blood 
0600 Biopsy 3 
 
 
 
 
 
 
 
 
 
 
 
  
1. Day 2 is scheduled 1 week after Day 1 testing; Day 3 follows Day 2. 
2. All assigned meals matched for macronutrient and caloric content. 
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  Figure 2. Study Timeline 
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Those randomized into the I group were administered their post exercise nutrition 
immediately post exercise.  The D group was instructed to drink their nutrition at 2 hours 
post exercise.  On testing days, the D group was given the shake at 2 hours post exercise.  
The T1-Day 3 biopsy was at 24 hours post T1-Day 2 2H2O dose 1.  Subsequent to the T1 
series, T2, (4 wks) and T3 (8 wks) testing collected resting measures and program 
compliance data.  The final testing series (T4) was scheduled at the 12 week point of the 
study.  The timeline for the T4 series was identical to that of T1 series, as were the 
testing procedures. 
Training Protocol 
 All participants attended, and participated in the 30 minute Curves circuit three 
times per week for 12 weeks while maintaining a greater than 80% compliance record.  
The circuit is comprised of 13 hydraulic resistance exercise stations involving 
bidirectional patterns working all major muscle groups, interspersed with floor-based 
exercises/recovery stations designed to maintain a target heart rate specific to each 
participant.  Stations were timed from 30-60 seconds, monitored & adjusted for 
subsequent sessions via the Curves Smart technology to optimize intensity levels of each 
workout throughout the training period.  On one of the three days, a Zumba® exercise 
dance session was implemented into the workout.  The Curves circuit is located in the 
ESNL.  Trained research assistants, Circuit Coaches, and a Zumba instructors monitored 
sessions.  Attendance was monitored through the Curves Smart Admin application. 
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Dietary Intervention 
 Participants maintained Phase I (1200 calories/day) exercise & diet program for 
one week, then progressed to Phase II (1500 calories/day).  They continued Phase II for 
the remaining 11 weeks of this 12 week prospective exercise, diet & timing clinical trial.  
Previous research has shown that a Curves 10-week program promotes a 10 – 15lb 
weight loss [140,233].   All participants followed the same HP diet plan as outlined in 
the Curves high protein diet program [141], which outlines a predetermined 
macronutrient intake of 30% carbohydrate, 45% protein, and 25% fat throughout the 
study.   
 Table 2 presents the dietary intervention protocol employed during the study.  
Participants in the I group (01) were provided the timed nutrition immediately post 
exercise.  This intake consisted of a Curves Shake mixed with water, and is similar in 
taste, appearance, texture, and composition to other readily available commercial 
nutritional products.  The timing of the intake was the only difference in the dietary 
routine between groups.  The D group (02) ingested their shake at 2 hours post exercise.  
A detailed nutrient analysis of the timed supplement is presented in Table A3 (pg. 130).  
Meals were controlled for caloric and macronutrient content during the T1 and T4 
testing routines of all participants as typified in Table 2.  It is of interest to note: based 
on diet as designed with our participants, we estimate a protein consumption of  
approximately 3-4g/kg Lean Mass (LM)/day throughout the 12 week intervention. 
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Table 2. Dietary Intervention Outline 
Diet Period 
Study 
Group 
 
Macro- 
Nutrient 
 
 
Gms/ 
Day 
 
Kcals/ 
Day 
 
Percentage of 
Daily Diet 
 
Phase I 
 
(One week) 
3 x/week 
Monitored 
Exercise, 
& 1x/wk Zumba  
 
Nutrition                                 
(1,200 kcals/day) 
(n=20) 
 
+ 
 
Timed Shake 
(accounted for in diet) 
 
 
 
 
Protein  
Carbohydrate 
Fat 
 
 
Protein 
Carbohydrate 
Fat 
 
135 
90 
33.3 
 
 
15 
8 
1.5 
 
540 
360 
300 
 
 
60 
32 
13.5 
 
45 
30 
25 
 
 
.05 
.03 
.01 
Phase II 
 
(Eleven Weeks) 
3 x/week 
Monitored 
Exercise, 
& 1x/wk Zumba 
Nutrition 
(1,500 kcals/day) 
(n=20) 
 
+ 
Protein 
Carbohydrate 
Fat 
 
168.75 
112.5 
41.67 
 
 
 
675 
450 
375 
 
 
 
45 
30 
25 
 
 
 
 Timed Shake 
(accounted for in diet) 
Protein 
Carbohydrate 
Fat 
15 
8 
1.5 
 
60 
32 
13.5 
.04 
.02 
.009 
 Caloric content: Fat (1g=9kcal); CHO (1g=4kcal); Pro (1g=4kcal); Alcohol (1g=7kcal) 
 
Testing Procedures 
Following the familiarization session and during the week prior to T-2, 
participants recorded all food/drink (other than water) consumption on dietary record 
forms (Food Logs) for four days.  Food logs were turned in at each testing session, & 
analyzed by Food Processor SQL Nutrition Software (ESHA Nutrition Research, Salem, 
OR).  Activity logs were turned in weekly, and utilized for exercise & activity 
compliance tracking. 
 Participants were instructed to refrain from exercise for 48 hours, and dietary 
intake for 12 hours prior to the initiation of each scheduled testing session.  They 
reported to the ESNL, or the Human Countermeasures Laboratory (HCL) for testing.  
Upon reporting to the ESNL, participants completed the SF-36 Quality of life (QOL) 
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inventory [238], an appetite/eating satisfaction questionnaire, body image, activity log, 
and International Physical Activity Questionnaire (IPAQ).  Participants were required to 
complete a follow-up side effect report at each testing session to facilitate monitoring for 
any concerns regarding exercise or diet.  Validity and reliability of these tools are 
detailed in the previous chapter.  Following the study, participants were asked to 
complete a post-study questionnaire to assess impressions about the Curves Fitness & 
Weight Management Program. 
Resting Energy Expenditure 
 REE assessments were administered according to standard protocols using the 
Parvo Medics TrueMax 2400 Metabolic Measurement System (Sandy, UT).  This 
involved participants lying down on an exam table and placing a see-through metabolic 
canopy over the participant’s neck and head so that metabolic gas exchange could be 
measured.  The participant remained motionless (without sleeping) for 20-minutes.  
Metabolic measurements were recorded to determine resting oxygen uptake and energy 
expenditure. 
Bioelectrical Impedance Analysis 
Total body water was determined by bioelectrical impedance assessment (BIA) via the 
Impedimed DF-50 Bioelectrical Impedance Analyzer (San Diego, CA).  This unit 
measures bio-resistance of water and body tissues based on a minute low energy, high 
frequency current (500 micro-amps at a frequency of 50 kHz) transmitted through the 
body.  The analyzer is commercially available, and BIA has been used in the health 
care/fitness industry as a means to assess body composition and body water for over 20 
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years.  The use of this device has been approved by the Food and Drug Administration 
(FDA) to assess total body water, and the current to be used has been deemed safe.  
Measurement is obtained via four electrodes placed on the body per ACSM protocol: 
one electrode was placed on the posterior surface of the right wrist, between the radial 
and ulna styloid processes (wrist bones), another electrode was placed on the posterior 
surface of the right hand at the distal base of the second metacarpal; the third electrode 
was placed on the anterior surface of the right ankle between the lateral and medial 
malleoli, and the fourth electrode placed on the foot at the distal end of the first 
metatarsal.  Participants were positioned supine on an exam table with electrodes 
connected to the analyzer.  After connecting the participant; age, gender, weight, and 
height were manually entered into the unit.  After measurement (approximately 30 
seconds), the unit calculates total body water, intracellular and extracellular fluid, as well 
as a measure of body composition.  Bioelectric impedance analysis has been determined 
to be a valid measurement for total body water [235-237].   
Resting HR & BP 
 Resting HR and BP were determined before or after REE/BIA measurements.   
Resting heart rate was determined by palpitation of the radial artery using standard 
procedures [238], or via GE Dinamap Pro 1000 monitor (Milwaukee, WI), and prior to 
GXT preparation.  Blood pressure was assessed in the supine position after resting for 5-
min (and prior to GXT prep) using a mercurial sphygmomanometer as per standard 
procedures [238] or via the GE Dinamap Pro 1000. 
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Body Composition 
 Body composition/bone density assessment measures were determined using a 
calibrated Hologic (Bedford, MA) Discovery Dual Energy X-ray Absorptiometer 
(DEXA) by qualified personnel with x-ray technology training under the supervision of 
Richard B. Kreider, PhD, MX.  Quality control (QC) calibration procedures were 
performed on a manufacturer supplied & calibrated spine phantom prior to each testing 
session.  In addition, bi-weekly automated uniformity calibration procedures were 
performed when initiated by the instrument software.   
 The DEXA body composition test involved having the participant lye supine in a 
standardized position while wearing a pair of shorts/t-shirt or a gown.  A low dose of 
radiation scanned the entire body for approximately seven (7) minutes. The DEXA 
segments regions of the body (right arm, left arm, trunk, right leg, and left leg) into three 
compartments for determination of fat, soft tissue (muscle), and bone mass. Radiation 
exposure from DEXA for the whole body scan is approximately 1.5 mR per scan, which 
is similar to the amount of natural background radiation a person would receive in one 
month while living in the Bryan/College Station, TX area.  The maximal permissible x-
ray dose for non-occupational exposure is 500 mR per year. Total radiation dose was 
estimated to be less than 5mR for the entire study.  Test-retest reliability studies 
performed on male athletes with this model DEXA yielded mean deviation for total 
Bone Mineral Content (BMC) and total fat free/soft tissue mass of 0.31% with a mean 
intra-class correlation of 0.985. 
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Anthropometry 
 Hip and waist measures were performed per guidelines established by the 
American College of Sports Medicine (2001).  Hip and waist circumference were used 
to establish a ratio that has been shown to be a predictor of heart disease [144]. 
Phlebotomy & Blood Measures 
 Following these assessments, participants donated approximately 20 ml of 
fasting blood using standard venipuncture techniques.  Blood samples were analyzed by 
Quest Diagnostics for serum clinical chemistry profiles (glucose, total protein, blood 
urea nitrogen, BUN/creatinine ratio, albumin, calcium, total bilirubin, alkaline 
phosphatase, triglycerides, cholesterol, HDL, LDL etc.).  Whole blood analysis 
(including hemoglobin, hematocrit, red blood cell counts, white blood cell counts, 
neutrophils, lymphocytes, monocytes, eosinophils, basophils) were analyzed in the 
ESNL via the Abbot Cell-Dyn 1800 (Chicago, IL) during the 10 week intervention, or 
by Quest Diagnostics (Houston, TX).  Samples may have been run in duplicate to verify 
results if the observed values were outside control values, and/or clinical norms 
(according to standard procedures) when run in the ESNL via the Cell-Dyn. 
 Participants fasted overnight for 12 hours and donated approximately 4 teaspoons 
of fasting venous blood (20 milliliters).  Blood samples were be obtained using standard 
phlebotomy procedures via sterile venipuncture of an accessible vein by laboratory 
technicians trained in phlebotomy, and in compliance with guidelines established by the 
Texas Department of Health and Human Services.  Lab staff wore personal protective 
clothing (gloves, lab coats, etc.) as appropriate when handling blood samples, which 
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were processed in a protective laboratory environment.  Participants were seated in a 
phlebotomy chair, and their arm cleaned with a sterile alcohol wipe and sterile gauze.  A 
standard rubber tourniquet was placed on the brachium, and an antecubital vein palpated.  
Then, a 21-22 gauge sterile (or 23 gauge butterfly) needle attached to a plastic vacutainer 
holder was inserted into the selected vein using standard procedures.  Two or three 
serum separation vacutainer tubes (red or “tiger” tops) and one EDTA vacutainer tubes 
(purple top) were inserted in succession into the vacutainer holder for blood collection 
using multiple sample phlebotomy techniques.  Once samples were obtained, the 
vacutainer holder and needle were removed, and discarded as hazardous waste in 
appropriate containers.   
 Finally, the venipuncture site was covered with clean gauze and tape (or a Band-
Aid) was placed on the site.  The blood collection tubes were labeled and placed in a test 
tube rack pending further processing. 
Laboratory technicians (who had received blood borne pathogen training and 
were wearing personal protective clothing) centrifuged the serum samples, transferred 
the serum into labeled serum storage containers, and prepared samples for storage in a 
refrigerator when blood was analyzed by Quest, or a -80 degree freezer for subsequent 
analysis within the ESNL. 
Graded Exercise Testing 
 Participants performed a graded maximal exercise test (GXT) according to the 
protocol outlined in Table 3.  GXT were performed by lab exercise physiology graduate 
students in accordance with standard procedures described by the American College of 
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Sports Medicine’s (ACSM) Guidelines for Exercise Testing and Prescription.  This 
involved preparing the participant’s skin for placement of 10 ECG electrodes.  Electrode 
sites were cleansed with sterile alcohol gauze using a circular motion, then allowed to air 
dry (or dried with a gauze pad).  Electrodes were then placed as follows: right 
subclavicular fossa (RA), left subclavicular fossa (LA), right abdomen (RL), left 
abdomen (LL), 4th intercostal space at the right sternal border (V1), 4th intercostal space 
at the left sternal border (V2), equidistant between V2 and V4 (V3), 5th intercostal space 
at the midclavicular line (V4), 5th intercostal space at the anterior axillary line (V5), and 
5th intercostal space at the mid-axillary line (V6) of the chest.   
 The participant was then attached to a Cardio System ECG monitoring system 
(Nasiff Associates, Inc., Brewerton, NY).  Resting blood pressure, heart rate, and a 12-
lead ECG were obtained.  Prior to the GXT, trained ESNL staff reviewed the supine 
resting 12-lead ECG to ensure that no contraindications for exercise testing were 
apparent based on the ACSM guidelines.  Participants were then asked to stand on the 
treadmill, where a standing (resting) ECG was assessed for contraindications.  A 
sanitized clean mouthpiece was attached to a head harness and secured on the 
participant.  A nose-clip was placed on the participant’s nose, and resting expired gases 
were collected using the Parvo Medics 2400 TrueMax Metabolic Measurement System.  
Once the participant was ready to begin the test protocol, they straddled the treadmill 
with both legs (alternately stood on the GXT belt with hands momentarily on handrails 
for stability), and the automated GXT protocol was initiated at a speed of 2.0 mph and at 
a 0% grade for a 2-minute warm-up period.  Participants placed one foot onto the belt, 
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and repeatedly swiped the belt in order to gauge the speed of the motion.  Once the 
participant was familiar with this speed, they stepped onto the belt (both feet) while still 
gripping the handrails with both hands.  Once the participant was comfortable walking 
on the treadmill, they released the handrails and began walking freely.  Subsequent to 
the warm-up, each participant performed a standard symptom-limited (Bruce Protocol) 
treadmill maximal exercise test as outlined below in Table 3 below. 
          Table 3. GXT (Bruce Protocol) 
Stage Speed Grade (%) Duration(min) 
1 1.7 10 3 
2 2.5 12 3 
3 3.4 14 3 
4 4.2 16 3 
5 5.0 18 3 
6 5.5 20 3 
7 6.0 22 3 
 
 Each participant was encouraged to exercise to their maximum unless they 
exhibited clinical signs to terminate the exercise test as stated by the ACSM’s Guidelines 
for Exercise Testing and Prescription [i.e., angina, dyspnea, dizziness, a decline in 
systolic blood pressure, dangerous dysrhythmias (increasing or multi-form premature 
ventricular contractions, ventricular tachycardia, supraventricular tachycardia, new atrial 
fibrillation, or A-V block), lightheadedness, confusion, ataxia, cyanosis, nausea, 
excessive rise in systolic blood pressure over 250 mmHg or diastolic over 120 mmHg, 
chronotropic impairment, failure of the monitoring system, or other signs or symptoms 
for terminating the test].   
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 The test was terminated at the request of the participant, or when undue signs of 
exhaustion were observed which might have increased risk of any adverse event.  Once 
the exercise test was complete, participants were observed for a 3 minute active recovery 
period, followed by a 3 minute seated recovery period.  The normal exercise time to 
maximum for the modified Bruce treadmill protocol in untrained women is typically 
about 9-12 minutes (near the completion of stage III or just entering stage IV).  Heart 
rate (HR), ECG tracings, and expired gases were monitored continuously throughout the 
entire exercise test process.   Blood pressure (BP) and ratings of perceived exertion 
(RPE) were obtained toward the end of each stage.  Participants were asked to report any 
unusual signs or symptoms to the exercise administrator during the exercise test.  This 
GXT determines maximal aerobic capacity, and anaerobic threshold to discern the 
effects of exercise training on fitness and exercise capacity.  The mean coefficient of 
variation (assessing Vo2Max) for this protocol is 6.5% (range 2-14%). 
Strength Testing (1RM) 
 Participants then performed 1 repetition maximum (1RM) lifts on the bench press 
and leg press to assess strength.  Each participant performed as many repetitions as 
possible with 80% of their 1RM effort for upper and lower body endurance testing.  
Participants completed 1-RM leg press (LP) & bench press (BP) lifts to determine lower 
and upper body strength respectively.  While participants were seated in the LP 
apparatus, (Nebula Fitness, Inc., Versailles, OH) foot placement was such that the 
participants’ feet were about shoulder width apart.  This placement was recorded by 
using numbers placed on the leg press foot plate to ensure consistency between lifting 
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bouts.  Placement of the leg press sled height was also recorded to ensure the correct 
range of motion for each participant.  Proper technique was described to the participant, 
and technique monitored throughout the testing session to ensure internal validity and 
consistency between participants.  Proper technique included lowering the LP sled until 
the knees were at a ninety degree (90°) angle, placing the hands on the handle bars 
located at the side of the equipment to prevent the arms from pushing on the legs, 
keeping the knees in line with the feet and keeping the back and gluteals in constant 
contact with the LP seat.  Participants then completed a 1-RM LP test adapted from the 
National Strength and Conditioning Association (NSCA) guidelines [239]: 
1) Primary staff instructed the participant to warm up with a light resistance that 
easily allows 5-10 repetitions. 
 
2) Provided 2 minute rest period. 
 
3) Estimated a warm up load to allow the participant to complete ~3-5 
repetitions by adding ~30-40 pounds or ~10-20% for lower body exercise and 
attempt 1 repetition.  If successful,  
 
4) Provided a 2 minute rest period 
 
5) Estimated a conservative, near maximum load that would allow the 
participant to complete ~2-3 repetitions by adding ~30-40 pounds or ~10-
20% for lower body exercise and perform 1 repetition.  If successful, 
 
6) Provided a 2 minute rest period 
 
7) Made a load increase of  ~30-40 pounds, or ~10-20% for lower body exercise 
 
8) Instructed the participant to attempt a 1RM. 
 
9) If the participant was successful, provided a 2 minute rest period and returned 
to step 7.  If failed, provided a 2 minute rest period, decreased the load by 
~15-20 pounds or ~5-10% for lower body exercise, and returned to step 8.  
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Load was continually increased until the participant could no longer complete one 
repetition.  Ideally, the participant’s 1RM was measured within 5 testing sets. 
Likewise, a 1RM BP was conducted to determine upper body strength using the same 
protocol.  All strength/exercise tests were supervised by lab assistants experienced in 
conducting strength/anaerobic exercise tests using these standard procedures.   
Circuit Baseline Testing 
Finally, on T-1 day 1, participants then moved to the Curves Circuit baseline 30 
minute familiarization & assessment.  This session consisted of 2 sets of 3 repetitions on 
each of the 13 stations under direct supervision, and with specific individual instruction 
by a trained ESNL research assistant staff member.  The first set was to determine 
appropriate (optimal) range-of-motion (ROM), while the second set established a 
reference force for maximal effort. 
T1 & T4 (Day 2 & 3) Routine 
 One week subsequent to the above measures (to allow for adequate recovery 
from baseline exercise testing) and on T-1 day 2 (as outlined in Table 1), participants 
ingested timed doses (1-4) of the 2H2O, had associated intermittent blood draws to 
determine equilibration levels for the 2H2O, performed the first exercise session, ingested 
the timed nutrient intake and received muscle biopsies 1.1 (baseline) through 1.3 at 
timed intervals (Table 1).  Additionally, predetermined HP meals were ingested at timed 
intervals.  These meals were controlled for macronutrient and caloric content.  The 
exercise session consisted of a 30 minute training bout, followed closely by biopsy 1.2.  
Deuterium doses 3 & 4 were administered at 7.5 & 9 hours, respectively on day two of 
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testing.  Day three of T1 testing consisted of a 5th blood draw, and biopsy 1.4 at 24 
hours post exercise.  This process was repeated at testing session 4 (the final 3-day 
testing period).  Testing sessions T2 & T3 included resting measures only at 4 & 8 
weeks respectively, and were designed to monitor and promote participant compliance. 
2H2O Dosing 
 Timed 2H2O ingestion was utilized to facilitate physiological measurement of 
FSR through the use of periodic skeletal muscle tissue (biopsy) analyses at timed 
intervals throughout the available assessment period as typified in Table 1.  This method 
allows for measurement of alanine via stable isotope pools over the 24 hours of each (T-
1 & T-4) testing session.  Ingestion was administered in 4 doses of approximately 1.625 
ml/kg lean mass for each participant at time-points as outlined previously, for a total 
administration of ~6.5 ml/kg lean mass over the 10 hour period.  As suggested earlier, 
these administrations were implemented only during the first and last testing sessions.  
2H2O consists of a stable isotope with no documented physiological disadvantages other 
than nausea, dizziness or other similar side effects when administered in larger dosages 
than were given during this study [202]. 
  The 6.5 ml was diluted with distilled water, to effect a 70% 2H2O concentration 
(for palatability, and to minimize side effects).  Here is an outline of a typical dosing 
routine for T-1 & T-4 as previously presented in Table 1. 
 
 
 
 72 
 
0600 - Blood, 2H2O dose 1.1/4.1 
0630 - Curves Breakfast 
0800 - 2H2O dose 1.2/4.2 
0845 - Blood, Biopsy 1.1/2.1 
0915 - Circuit Workout, -post exercise nutrient intake (I Group only) 
1030 - Blood, Biopsy 1.2/2.2 
1230 - Blood, Biopsy 1.3/2.3 
1300 - Curves Lunch 
1330- 2H2O dose 1.3/4.3 
1530 - Blood, 2H2O dose 1.4/4.4 
1730 - Curves Dinner 
  
Muscle Biopsies & Follow-up Care 
The six (3 each for T1 & T4) percutaneous muscle biopsies (50-125 mg each) 
were obtained over the duration of the study from the middle portion of the right or left 
vastus lateralis muscle at the midpoint between the patella and the greater trochanter of 
the femur and at a depth between 1 and 2 cm.  For T1 & T4 biopsies, samples were 
extracted from sites adjacent to previous biopsies, rather than from previously accessed 
sites.  All biopsies were extracted by trained and experienced personnel in the Human 
Countermeasures Laboratory at Texas A&M University.  After sample extraction, any 
necessary adipose tissue was trimmed from the muscle specimens.  Subsequently, the 
muscle samples were immediately frozen in liquid nitrogen, and stored at -80C awaiting 
future analysis. 
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Muscle samples were extracted under local anesthesia of 2% Xylocaine from the 
middle portion of the muscle midway between the patella and the greater trochanter of 
the femur.  First, the participant was placed supine, to assume a comfortable reclining 
position on an examination table. Once the extraction point was identified, the area was 
wiped with an alcohol pad, and further be cleansed by swabbing (with a circular pattern 
outward from the selected site with Betadine (fluid antiseptic) and then draped.  A small 
area of the skin approximately 2 cm in diameter was anesthetized with a 1.0 mL 
subcutaneous injection of Xylocaine.  Once the local anesthesia had taken effect 
(approximately 2-3 minutes) each biopsy procedure took approximately 15-20 seconds.  
A scalpel point was used to access the biopsy site by making an incision approximately 1 
cm in length through the skin, subcutaneous fat, and fascia.  Due to the localized effects 
of the anesthetic, participants were observed to feel little or no pain during this process. 
The biopsy needle was advanced into the incision approximately 1 cm.  During this 
procedure, subjects were observed to feel pressure and/or discomfort to the thigh area.   
Once the muscle sample was extracted, direct pressure was immediately applied.  
The site was subsequently closed, and the wound dressed with a pressure bandage.  Due 
to the small incision site, only minimal bleeding was observed.  The needle and scalpel 
blade were cleaned in an antiseptic solution and subsequently autoclaved for future use, 
or discarded as hazardous waste in an appropriately-labeled plastic sharps container.  All 
waste was discarded in an appropriately labeled biohazard waste receptacle.  Tissue 
samples were stored at – 80C for future analyses.     
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Written instructions for post-biopsy care were reviewed and issued to 
participants (Appendix).  Each participant was instructed to leave the bandages on for 24 
hours (unless unexpected bleeding or pain occurred) and asked to report back to the lab 
within 24 hours to have the old bandages removed, the incision inspected and new 
bandages applied.  Participants were further advised to refrain from vigorous physical 
activity (with the exception of directly supervised study related exercise) during the first 
48 hours post-biopsy.  These suggestions were designed to minimize pain and possible 
bleeding of the area.  If needed, the subject was instructed to take non-prescription 
analgesic medication such as Tylenol or Ibuprofen to relieve pain (Appendix).  
However, medications such as aspirin, Nuprin, Bufferin, or Advil were discouraged as 
these medications may lead to ecchymosis at the biopsy site.  Participants were 
instructed that soreness of the area may occur for about 24 hours post-biopsy. 
Tissue Processing & Metabolic Analysis 
 Skeletal muscle biopsy samples were processed and analyzed as previously 
described [196,206,211,212] via gas chromatography/mass spectroscopy (GC/MS), as 
this method has been utilized repeatedly in the Muscle Biology Laboratory at Texas 
A&M University.  Briefly, and as described elsewhere [196] 10-20uL of plasma and 
~30mg of muscle tissue was necessary for the 2H-labeled/unlabeled ratios by GS-MS.  
For quantification, the 2H enrichment of acetone was analyzed following exchange with 
the 2H-labeling of body water[240], and the methyl-8 derivative of protein bound 2H-
labeled alanine after reaching the hydrolysate with N,N-
dimethylformamidedimethylacetal[241].  The use of stable isotopes do not require 
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parallel measurements of the tracer (alanine) concentration since the GC-MS 
simultaneously measures the labeled and unlabeled molecules, allowing for immediate 
calculation of the ratio.  This is dissimilar to radioisotopes, which require knowledge of 
the total concentration of the amino acid for determination of the specific activity[196]. 
 The 2H labeling of protein-bound alanine was measured as previously described 
[212].  Briefly, ~ 0.030 g of muscle is homogenized on ice in 0.3 ml of a 10% (wt/vol) 
TCA and centrifuged at 3,750 rpm at 4°C for 15 min.  This was repeated 3 additional 
times prior to dissolving the protein pellet in 6 N HCl (0.1 mL/0.030 g tissue) and 
reacting at 100ºC for 18 h.  All samples were analyzed using an Agilent 5973N-MSD 
equipped with an Agilent 6890 GC system, and a DB17-MS capillary column (30 m × 
0.25 mm × 0.25 µm) was used in all analyses. The following temperature program was 
used: 90ºC initial, hold for 5 min, increase by 5°C/min to 130ºC, increase by 40ºC/min 
to 240ºC, and hold for 5 min. The sample was injected at a spit ratio of 5:1 with a helium 
flow of 1 mL/min. Alanine eluted at ~12 min. The mass spectrometer was operated in 
electron impact mode.  Selective ion monitoring of mass-to-charge ratios (m/z) 99 (M) 
and 100 (M + 1) was conducted using a dwell time of 10 ms/ion. 
 FSR of mixed muscle proteins (FSR) were obtained by measuring the 
incorporation of 2H alanine into protein (EA) and using the precursor-product model,  
FSR = EA/(EBW∙ 3.7 · t) 
where EA represents amount of protein-bound 2H Ala (%), EBW is the quantity of 2H2O in 
body water (%), 3.7 represents the exchange of 2H between body water and alanine 
[206,212,242], and t is time of label exposure (24 h).  More recently, the Muscle Biology 
 76 
 
Lab at Texas A&M reported the measurement as the rate at which 2H-labeled alanine is 
incorporated into muscle protein(s) relative to the total abundance of the alanine pool per 
unit of time (fractional synthesis rate, FSR) and can generally be calculated by the 
equation: 
FSR= [(MPEAla)] / (n×MPEBW × t) ×100, 
where MPE (mole percent excess)Ala represents the total 2H-labeling of protein-bound 
alanine, "n" represents the exchange of 2H between body water and free alanine 
(~3.7 in mammals), MPEBW represents the labeling of body water and “t” is time[196].. 
Statistical Analyses 
 An a-priori analysis using related studies[243,244] was conducted to determine 
an appropriate sample size. A small effect size was defined as power (1-β) = 0.20, a 
medium effect size power = 0.5, and a large effect size power = 0.80 [249].  At α = 0.05, 
the a-priori power analysis suggested that a sample size of 10/group would yield a power 
of ~0.53, which intimates detection of a medium effect as defined by Kirk.
 Study data were analyzed via Multivariate Analysis of Variance (MANOVA) 
with repeated measures (IBM SPSS Statistics, v. 21, 2012, Armonk, NY).  MANOVA 
effects were examined using Wilks’ Lamda time and group x time p-levels as well as 
univariate ANOVA group effects.  Greenhouse-Geisser univariate tests of within-
subjects time and group x time effects, and between-subjects univariate group effects 
were analyzed for each variable within the MANOVA.  In some instances, repeated 
measures ANOVA were run on variables where group, time, and group x time 
interaction effects were of interest.  Analysis of Covariance (ANCOVA) was used to 
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assess baseline homogeneity.  Delta values and/or percent differences were calculated 
and analyzed on select variables via ANOVA for repeated measures to assess % change 
from baseline.  Delta values were calculated by subtracting the T1 from T4 values, then 
performing division by T1, followed by multiplication by 100 
    [(T4-T1)/T1*100]. 
 Data were considered statistically significant when the probability of type I error 
was 0.05 or less.  Statistical trends were considered if the probability of type I error 
ranged between >0.05 to <0.10.  If a significant group, treatment and/or interaction alpha 
level was observed, Tukey’s least significant difference (LSD) post-hoc analyses were 
performed to determine where significance was obtained.  Missing and outlier variable 
data were addressed via the group mean method.  However, neither removal of cases 
with missing data, nor replacement of missing data was determined to significantly 
affect final results.  
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CHAPTER IV 
RESULTS 
 This nutrient timing prospective clinical trial included 21volunteers that 
completed the 12 week intervention.  Twenty two participants were recruited, with 1 
drop after completing the first testing session due to musculoskeletal concerns under the 
advisement of her Chiropractor.  One participant cited recurrent musculoskeletal 
complaints unrelated to the intervention, and did not complete lower body strength 
testing during T-4.  A second participant experienced nausea during early stages of day 
two of her first testing session (she had received her first two doses of D2O) and elected 
not to complete the session.  All participants signed informed consent statements that 
were in compliance with the Institutional Review Board at Texas A&M University, and 
were randomized into either the I or D group.  Participants were also matched, and 
homogeneity was compared to randomization revealing no significant differences 
between the two methods.  All 21 participants completed a 12 week exercise and dietary 
weight loss intervention that included 4 testing sessions, and were included in the 
analyses.  There were 12 participants in the Immediate (I) and 9 participants in the 
Delayed (D) group (n = 21).Our flowchart in Figure 3 outlines the logistical sequencing 
for the NT study participants. 
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         Figure 3. NT Consort Diagram 
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Demographics 
Baseline demographics were analyzed via ANOVA with no significant baseline 
differences noted between groups based on age, height, weight, BMI [(weight (kg) / 
[height (m)]2 or lean mass (LM). Table 8 depicts demographic data for age, weight, 
height, BMI, and LM for all participants.  The recruitment age was between 50-70 years 
old.  One-way ANOVA revealed no statistically significant differences of baseline 
values between these variables. 
  Table 4. Baseline (T-1) Group Demographics 
Variable Mean ± SD F p 
Age (years) 59.8 ± 5.2 2.3 0.15 
Weight (kg) 84.85 ± 8.9 .013 0.91 
Height (cm) 65.19 ± 2.5 1.4 0.25 
BMI 31.00 ± 3.0 .48 0.50 
LM (kg) 42.55 ± 5.3 .149 0.70 
Nutritional Intervention 
In lieu of the focus on timed nutrition for this study, a brief review of the dietary 
intake data are warranted.  Both the “I” (timed nutrition immediately post-exercise) and 
“D” (timed nutrition 2 hours post-exercise) group were assigned a dietary calorie intake 
regime consisting of 45% protein, 30% carbohydrate and 25% fat; with a total intake 
goal of 1,200 calories/day for week 1, then 1,500 calories for the remaining 11 weeks 
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(maintenance phase).  Nutritional goals for both groups were inclusive of the post 
exercise nutrition in the form of a vanilla shake containing 15g protein, 8g carbohydrate 
and 1.5g fat immediately following (I), or 2-hr after (D) resistance exercise as part of 
their nutrition program.  Throughout the 12 week intervention, protein intake averaged  
2.21g/kg/day Lean Mass (LM).    
 Table 5 outlines nutritional intake data, and provides a visual representation of 
caloric and macronutrient percentages for each testing session as recorded via 4-day 
food logs at each of the four testing sessions.  There were no significant within or 
between group differences in caloric (p=0.952) or macronutrient (Pro: p=0.543; CHO: 
p=0.685; Fat: p=0.182) intake throughout the study duration. 
 Mixed Muscle Protein Synthesis (FSR) 
 Figure 4 shows FSR changes over the course of the study.  Based on ANOVA 
analyses, no significant nutrient timing x training interactions (mean±SEM) were 
observed in muscle FSR, expressed as a percent/day of the alanine pool (I-Pre 13.6±4.3, 
I-Post 21.1±4.3; D-Pre 15.6±4.0, D-Post 23.8±4.0 %/d, p=0.93).  However, FSR was 
augmented (p<0.05) in response to a bout of exercise for both pre-training (14.6±2.9 
%/d) and post-training (22.5±2.9 %/d) interventions.  FSR tended to be 54% higher 
(p=0.075) in response to the post-training bout of exercise when compared to pre-
training values.  Protein synthesis rates trended upward over the course of our 12-week 
intervention with overweight post-menopausal women. 
No significant differences were observed in FSR (% · h-1) between the 
Immediate and Delayed groups in mixed muscle when assessed 16 h following pre or 
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post exercise sessions (measured over 24 h).  Our results are inconsistent with HA1 and 
HA2: Timed nutrition will significantly enhance pre-training FSR (HA1), and post-
training FSR (HA2) in the Immediate compared to the Delayed group. 
 
      Table 5. Dietary Summary 
Variable Group Baseline 
 
 1mo 2mo 3mo p-level 
Calories 
(Kcal/d) 
I 1,371 
±213 
 1,353 
±201 
1,270 
±251 
1,290 
±200 
Group                  p=0.95 
Time                    p=0.07 
D 1,354 
±154 
 1,308 
±169 
1,338 
±157 
1,255 
±111 
Group x Time      p=0.34 
  Time  
Mean   
 
1,364 
±186 
 1,334 
±185 
1,299 
±214 
1,279 
±165 
 
Protein 
(%/d) 
I 21.33 
±9.04 
 33.22 
±8.42 
30.75 
±8.31 
30.23 
±7.55 
Group                  p=0.54 
Time                    p=0.02 
D 19.29 
±4.36 
 30.06 
±9.28 
29.30 
±7.70 
33.25 
±6.73 
Group x Time      p=0.25 
Time  
Mean   
 
20.45 
±7.32 
 31.92 
±8.73 
30.13 
±7.89 
31.50 
± 7.20 
 
Carbs. 
(%/d) 
I 41.95 
±9.6 
 30.80 
±6.42 
34.97 
±8.37 
35.69 
±7.2 
Group                  p=0.69 
Time                    p=0.00 
D 37.22 
±5.85 
 34.27 
±7.46 
34.04 
±5.19 
32.94 
±7.2 
Group x Time      p=0.46 
Time  
Mean  
 
39.92 
±8.37 
 32.29 
±6.44 
34.58 
±7.04 
34.51 
±7.16 
 
 Fat 
(%/d) 
I 34.37 
±6.37 
 34.53 
±7.89 
33.16 
±8.27 
32.92 
±6.04 
Group                  p=0.18 
Time                    p=0.01 
D 42.85 
±4.15 
 35.66 
±9.64 
36.66 
±6.08 
33.54 
±5.04 
Group x Time      p=0.05 
Time  
Mean  
 
38.01 
±6.90 
 35.01 
±8.47 
34.66 
±7.46 
33.19 
±5.51 
 
       Note: Data represents caloric (kcal/day±sd) and macronutrient intake values (% / day) for                        
the study.  Macronutrient targets - 45%PRO; 30%CHO, and 25%FAT throughout the study.  1mo = 1 
month; 2mo = 2 months; 3mo = 3 months.  Carbs. = Carbohydrate; I = Immediate; D = Delayed. 
Wilks Lambda results- Group: F(4,15) = 1.784, p = .184, Time: F(12,7) = 1.59. p = .275, 
Group*Time: F(12,7) = .720, p = .553 
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   Figure 4.Group Mixed Muscle FSR Changes 
 
 
Immediate post-exercise timed nutrition did not significantly impact FSR increase when 
compared to 2-hour delayed post-exercise intake.  If fact, the reverse seemed to be more 
of an encouraging possibility.  Both HA1 and HA2 are rejected. 
Figures 5 and 6 depict changes in fractional synthesis rate (FSR) for plasma 
percent/hour (Figure 5) and mixed muscle percent/day (Figure 6) of the alanine pool 
values in mole percent excess (MPE) from baseline.  Data represent T1 (pre-training) 
and T4 (post-training) results including pre and post exercise measures.  2H2O dosage 
was administered at a dosage of 6.5mL/kg lean mass achieving an overall mean 24 hour 
MPE of 0.512.  Body water 2H enrichment reached ~0.5 % excess over the course of the 
study, and 2H labeling of alanine did not differ between the immediate (I) and delayed 
(D) groups.  Both plasma and muscle 2H enrichments were adequate for FSR 
calculations.   
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        Figure 5.Plasma MPE changes 
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      Figure 6. Mixed Muscle MPE changes 
 
 
Body Composition 
Table 6 and Figure 7 outline MANOVA body composition results over the 12 
week course of diet and exercise intervention.  Over the duration of the 12 week study 
(time effects), participants in both groups lost weight (-3.9±3.2 kg, p=000) and fat mass 
(-4.1±2.4 kg, p=0.000).  However, no significant differences (mean±SD) were observed 
among groups in weight (I -3.6±2.3; D -4.2±4.2 kg, p=0.68) or fat mass (I -3.5±1.4; D -
4.8±3.3, p=0.26).  FFM tended to increase (0.5±1.6 kg, p=0.12) with no differences 
observed among groups (I 0.03±1.7; D 1.11±1.3 kg, p=0.14). While significant time 
effects were seen in body mass, fat mass, and encouraging time effects for REE and 
percent body fat; no significant group x time effects were observed. 
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      Table 6. Body Composition Data 
Variable Group Baseline 
 
 12 Weeks Source Sig. 
(p-value) 
F  Power 
Fat Free 
Mass  
(kg) 
I 44.549 
±6.209 
 44.581 
±5.553 
Group 
Time 
0.878 
0.064 
.024 
3.08 
 .052 
.528 
D 43.584 
±4.566 
 44.675 
±3.880 
G x T 0.538 .601  .31 
Time  
Mean   
 
44.136 
±5.457 
 44.622 
±4.794 
     
Fat Mass  
(kg) 
I 33.914 
±5.068 
 30.381 
±5.745 
Group 
Time 
0.184 
0.021* 
1.909 
3.926 
 .258 
.789 
D 35.115 
±3.816 
 30.330 
±5.192 
G x T 0.040* 3.268  .641 
Time  
Mean   
 
34.429  
±4.508 
 30.359 
±5.380 
     
Lean 
Mass  
(kg) 
I 42.945 
±6.091 
 42.981 
±5.397 
Group 
Time 
0.788 
0.000* 
.075 
12.98 
 .058 
.997 
D 42.016 
±4.425 
 43.105 
±3.711 
G x T 0.534 .661  .157 
  Time  
Mean   
 
42.547 
±5.335 
 43.034 
±4.640 
     
Body Fat 
(%) 
I 43.2 
±2.7 
 40.3 
±3.3 
Group 
Time 
0.184 
0.021* 
1.909 
3.926 
 .258 
.727 
D 44.6 
±3.7 
 40.3 
±4.5 
G x T 0.040* 3.268  .641 
Time  
Mean  
 
43.8  
±3.2 
 40.3 
±3.8 
     
Body 
Weight 
(kg) 
 
I 84.65 
±10.7 
 81.0 
±10.8 
Group 
Time 
0.969 
0.000* 
.002 
30.065 
 .050 
.999 
D 85.1 
±6.2 
 80.9 
±7.1 
G x T 0.680 .176  .068 
Time  
Mean   
 
84.88 
±5.457 
 80.91 
±4.794 
     
  
 
 
 
     
       Note: Data represents body composition variables for the study. Data was analyzed using univariate, 
multivariate and repeated measures general linear models (GLM).  Significant differences are                   
Indicated by an asterisk (*).  I = Immediate; D = Delayed; G = Group; T = Time. Wilks Lambda 
results- Group: F(4,15) = 1.784, p = 0.184, Time: F(12,7) = 1.59. p = 0.275, Group*Time: F(12,7) = 
.720, p =0 .553 
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         Figure 7. Body Composition Changes 
 
 
Although significant FM reduction was observed among groups over time, these results 
are inconsistent with HA3 and HA4.  Timed nutrition will significantly enhance FM loss 
(HA3) and LM gain (HA4) in the Immediate compared to the Delayed group over time.  
Immediate post-exercise timed nutrition did not significantly impact FM loss or LM gain 
when compared to 2-hour delayed post-exercise intake.  Therefore, HA3 and HA4 are 
rejected.
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Upper/Lower Body Strength 
Table 8 (as well as Figures 5 and 6) depict changes in upper and lower body 
strength over the 12 week training intervention.  Upper (bench press) and lower (leg 
press) body strength was assessed via 1RM testing during all four test sessions. ANOVA 
revealed there were significant changes in time main effect for one repetition maximal 
effort in the bench press (p=0.02) and leg press (p=0.03).  The mean percent changes in 
bench press one repetition maximal effort among groups were:  I 26.9 ± 37.5%; D 14.8 ± 
20.5%.  Overall mean percent 1RM change over time for bench press was 21.3 ± 27.7%.  
The mean percent changes for one repetition maximal effort leg press were: I 37.7 ± 
47.4%, D 37.1 ± 38.8%.  The overall mean percent change for one repetition leg press 
over time was 33.1 ± 36.9%.  Figures 5 and 6 depict 1RM changes in kg for UE and LE 
strength, respectively. 
Although significant 1RM UE and LE (p=0.02, 0.03 respectively) increases were 
observed among groups over time, these results are inconsistent with HA5 and HA6: 
Timed nutrition will significantly improve upper body strength (HA5) and improve lower 
body strength (HA6) in the I, compared to the D group over time.  Immediate (I) post-
exercise timed nutrition did not significantly impact UE or LE strength gain when 
compared to 2-hour delayed (D) post-exercise intake.  Therefore, HA5 and HA6 are 
rejected. 
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Table 7. Upper/Lower Body Strength Data 
Variable Group Baseline 
 
12 
Weeks 
Source Sig. 
(p-value) 
F  Power 
Bench 
Press 
1 Repetition 
Maximum 
(Kg) 
I 31.82 
±6.28 
33.71 
±5.72 
Group 
Time 
0.39 
0.02* 
.786 
6.06 
 .134 
,647 
D 28.79 
±6.53 
31.82 
±8.43 
G x T 0.58 .329  .547 
Time  
Mean  
 
30.52 
±6.41 
32.9 
±6.88 
     
Leg 
Press 
1 Repetition 
Maximum 
(Kg) 
I 150.0 
±22.74 
158.5 
±30 
Group 
Time 
0.40 
0.03* 
.734 
5.37 
 .128 
.592 
D 162.4 
±61.1 
180.8 
±63.9 
G x T 0.40 .736  .128 
Time  
Mean  
 
155.6 
±44.9 
168.5 
±48.2 
     
____________________________________________________________________________________ 
Note: Data represents upper and lower body strength testing variables for the study.  LSD post hoc 
analysis for time main effects is indicated numerically (p< 0.05).  * = represents p< 0.05 difference from 
baseline mean.  I = Immediate; D = Delayed; G = Group; T = Time. 
 
 
 
           Figure 8.Upper Body 1RM Gains 
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            Figure 9. Lower Body 1RM Gains 
 
 
Resting Energy Expenditure 
Table 20 illustrates that there are no statistically significant differences in group, 
time, or group x time for resting energy expenditure variables.  No differences were seen 
among groups in REE (I -18±146, -101±163, -82±126; D -46±137, -17±173, -90±142 
kcal/d, p=0.34).  Interestingly, a pairwise comparison of participant combined (Groups I 
&D) means did suggest a trend toward decreased REE over time [(Pre) 1,363±42; (Post) 
1,277±37; p= .085 (mean±SEM)].  Hence, our results are inconsistent with HA7: Timed 
nutrition will significantly improve REE (Kcal/day) in the I group compared to the D 
group over time.  Therefore, HA7 is rejected. 
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      Table 8. REE Data 
Note: Data represents Resting Energy Expenditure (Kcal/d) variables for the study.  
 I = Immediate; D = Delayed; G = Group; T = Time. 
    Figure 10. REE Changes 
Variable Group Baseline 12 
Weeks 
Source Sig. 
(p-value) 
F Power 
REE 
(Kcal/d) 
I 1,371 
±213 
1,290 
±200 
Group 
Time 
0.952 
0.085 
.004 
2.62 
.05 
.54 
D 1,355 
±154 
1,265 
±111 
G x T 0.473 .875 .201 
Time 
Mean 
(±SEM) 
1,363 
±42 
1,277 
±37 
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CHAPTER V 
DISCUSSION AND CONCLUSIONS 
Discussion 
Results of the current study demonstrate the effectiveness of diet with post 
exercise timed intake throughout a 12 week training evolution designed to elicit 
favorable changes in the fitness markers noted above. Throughout this 12 week study we 
found the following.  Diet and training promoted significant improvements in that both 
groups lost weight (-3.9±3.2 kg, p=0.00) and fat mass (-4.1±2.4 kg, p=0.00) with no 
significant differences (mean±SD) observed among groups in weight (I -3.6±2.3; D -
4.2±4.2 kg, p=0.68) or fat mass (I -3.5±1.4; D -4.8±3.3, p=0.26).  FFM tended to 
increase (0.5±1.6 kg, p=0.12) with no differences observed among groups (I 0.03±1.7; D 
1.11±1.3 kg, p=0.14).    
Significant improvements were observed for upper (p=0.02) and lower (p=0.03) 
body strength (1RM).  Mean percent bench press 1RM gains among groups (reported in 
Kg) were:  I 26.9 ± 37.5%; D 14.8 ± 20.5%, while overall mean percent 1RM bench 
press change over time was 21.3 ± 27.7%.  Mean percent changes for 1RM (reported in 
Kg) leg press were: I 37.7 ± 47.4%, D 37.1 ± 38.8%, and mean percent change over time 
for 1RM leg press was 33.1 ± 36.9%.  No differences were seen among groups in REE: 
(I -82±126; D -90±142kcal/d, p=0.34).  However, indications that REE may have 
slightly decreased (p=0.085) or remained unchanged over the 12 weeks of training. 
Based on our analyses, no significant nutrient timing x training interactions 
(mean±SEM) were observed on muscle FSR expressed as a percent/day of the alanine 
 93 
 
pool (I-Pre 13.6±4.3, I-Post 21.1±4.3; D-Pre 15.6±4.0, D-Post 23.8±4.0 %/d, p=0.93).  
FSR was augmented (p<0.05) in response to a bout of RE prior to training (14.6±2.9 
%/d) and trended higher (p=0.075) in response to a bout of exercise after training when 
compared to pre-training values (22.5±2.9 %/d). 
Both groups experienced improvements in strength, body composition and post-
exercise; post-training FSR with potentially greater effects observed in the Delayed 
group.  Total energy (Kcal) intake did not significantly differ between groups over time 
(p=0.073), suggesting a possible trend toward a decrease from baseline to 12 weeks.  
Both groups showed significant changes in macronutrient intake over time for protein 
(p=0.02), carbohydrate (p=0.00) and fat (p=0.01).  Protein remained below target of 
45%, while carbohydrate and fat approaching target (30% & 25% respectively).  
The Curves exercise and weight loss program has been shown to be effective 
with post-menopausal overweight females in promoting weight loss and favorable body 
composition changes.  Although there was a trend toward increased FSR with 2 hour 
post vs immediately post exercise nutrient ingestion, post exercise timed nutrition was 
generally not shown to effect significant changes. 
Ingestion of carbohydrate and protein prior to, and following exercise has been 
reported to influence protein synthesis.  For this reason, it is generally recommended to 
time nutrient intake around exercise to maximize results.  While there is a large body of 
evidence suggesting that nutrient timing influences acute responses to resistance-
training, it is less clear whether implementing such strategies during training may 
influence training adaptations.  There are also reports indicating that ingesting a higher 
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protein while participating in a resistance-training program may be an effective way to 
promote fat loss while maintaining lean body mass.  Theoretically, incorporating nutrient 
timing strategies during a weight loss program may help maintain lean mass to a greater 
degree.    
To our knowledge, this is the first study undertaken to directly investigating the 
effects of post exercise nutrient timing (24hr period, pre/post) over a 12 week higher 
protein/reduced carbohydrate diet with concurrent mixed exercise training on mixed 
skeletal muscle protein synthesis and related physiological variables in overweight to 
obese free living post-menopausal women. Herein, we specifically considered the effects 
of 1) a macronutrient controlled (45% protein, 30% carbohydrate and 25% fat) diet 
[primary interest in post exercise timed ingestion of a commercial protein shake (15g 
protein, 8g carbohydrate and 1.5g fat)], and 2) a combination resistance oriented 
exercise/training (circuit) program designed to elicit a general fitness response. 
Our dependent variables of interest included the health related fitness markers of: 
1) body composition: fat free mass (FFM), fat mass (FM) and body weight (BW); 2) 
strength (1RM upper & lower body) and 3) resting energy expenditure (REE).  
Primarily, our interest was directed toward post-exercise, pre/post-training mixed 
skeletal muscle fractional synthesis rate (FSR) as measured via 2H2O ingestion and 
subsequent skeletal muscle biopsies before/after exercise, and at 24 hours post initial 
2H2O loading dose as previously described herein.  Along with previous studies cited  
using similar methods, we were interested in cumulative muscle protein synthesis to 
encompass perturbations (sleep, exercise, activities of daily living and rest) that occur 
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daily in human overweight/obese post-menopausal women.  During this investigation, 
both the Immediate and Delayed post-exercise nutrition groups performed at equivalent 
training volumes, intensities, and frequencies. 
 Results have indicated that the exercise and diet program investigated was 
effective in promoting weight and fat loss without loss in lean mass.  Although it is 
settled science that exercise (perhaps more specifically resistance training) stimulates 
lean mass accretion, there is limited and less convincing evidence to suggest that 
resistance training (without an integrated well-managed diet) is as effective when it 
comes to fat mass reduction.  It is perhaps significant to note that a recent epidemiologic 
study comprised of 348 young adults over a 12 month period[246] concluded that, 
despite the limited effects on body mass index, exercise was associated with beneficial 
changes in body composition.  Most interestingly as related to our study, this meta-
analysis suggested that any exercise type positively affected LM in normal-fat 
participants, and reduced FM in overfat and obese adults.  Not surprisingly, they also 
reported that adults with excess body fat may benefit particularly from resistance 
exercise.  Our exercise intervention was of the mixed training variety, yet resistance 
training accounted for the bulk of training.  Arguably, perhaps most appropriately 
classified as resistance interval program training (RIPT). 
 The exercise, diet and/or post-exercise intake approach was effective in 
stimulating muscle protein synthesis post exercise during pre and post training 
interventions.  Protein synthesis stimulus persisted over the 24hr assessment period, and 
tended to be more pronounced following 12 weeks of training.  Specifically, 24hr group 
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Pre/Post (Immediate +7.5%; Delayed +8.2%) and total participant Pre/Post (Immediate 
+2%; Delayed +2.7%) mean increases in FSR were observed over the 12 week diet and 
exercise intervention. The mean FSR change from Pre to Post assessment for both 
groups combined was +7.85 percent.  Although several studies[18,21,137,247-249] have 
included a 24hr assessment for protein synthesis, virtually none have done so using our 
D2O method in a similar population with similar diet and exercise interventions.  
Therefore, it seems premature to compare 24hr synthesis rates from our study with 
others at the 24hr time point. 
 Based on joint TAMU Exercise Sport Nutrition Lab (ESNL) and Muscle Biology 
Lab (MBL) analyses of data collected in the ESNL and Human Countermeasures (HCL) 
labs, the anabolic effect of exercise was not significantly affected by prolonged training 
(although p = 0.075).  Nevertheless, FSR trended higher (54%) overall following 12 
weeks of the exercise and diet intervention.  It may be tempting to hypothesize that post-
exercise timed nutrition (nutrient timing) stimulated this increase in our population.  
However, as neither nutritional intake, nor exercise type/volume between groups was 
significantly different, might we just as easily attribute such results to our well-managed 
diet, total dietary protein intake, simply the training effect, or (perhaps more likely) 
both? 
 Reduced metabolism and lowered FSR rates throughout the aging 
process[27,179,250] may, if not hypothetically account for the afore mentioned trend.  
Exercise notwithstanding, since FSR in women has been reported as higher and less 
affected than that of men over the lifespan[251,252], a study such as ours may be of 
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interest in a male population as well.  Nevertheless, while a possible trend was observed 
warranting additional research, there did not appear to be any clearly distinguishable 
advantage of either immediate or delayed nutrient timing on 24-h FSR in our population 
of interest wherein a reduced carbohydrate, higher protein controlled diet was 
implemented throughout the study. 
 The ability to establish, or regain and maintain a healthy fitness level is a 
recommended component for optimizing quality of life.  In particular, this objective is 
perhaps of special concern for the post-menopausal overweight/obese female population.  
Considering numerous previously reported nutrient timing outcomes in young 
athletic[47,49,253] and more relevantly older populations[50,51,254-256] it is 
reasonable to posit that the timed post exercise nutrition administered during this study 
might significantly enhance FSR, thereby supporting anabolism and preserving, perhaps 
increasing lean mass.  Indeed, recent substantiating evidence for the positive effects of 
post exercise nutrient timing do exist[257-261].  However alternate studies which report 
mixed and/or questionable /inconclusive results also exist[28,30,54,262-264].  
Nevertheless, surprisingly few (if any) have utilized our methods, and/or targeted our 
specific population of interest. 
 The exercise and diet program administered during our study has shown marked 
benefits during previous studies consisting of younger and senior populations[139,265-
267], with more favorable results in participants randomized into higher protein diet 
groups.  The purpose of this study was to examine potential effects of timed (I and/or D) 
post-exercise protein intake, combined with the higher protein diet in obese post-
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menopausal women in the areas of mixed muscle FSR, measures of body composition to 
include fat mass, lean mass, upper and lower body strength (1RM), and resting energy 
expenditure (REE). 
 As previously noted herein, similar ESNL exercise and nutrition interventions 
have proven to be an effective approach for weight loss, specifically fat mass, while 
preserving muscle mass.  The greatest gains have been seen in groups where reduced 
dietary carbohydrate and higher protein were consumed.  Additional body composition 
gains were supported by time effects in waist and hip circumference.  Overall, both of 
our groups observed weight loss (I: -3.6kg; D: -4.2kg), fat loss (I: -3.5kg; D: -4.8kg), 
percent body fat (I: -2.8%; D: -4.38%) and maintained fat free mass (I: +0.03kg; D: 
+1.11kg).  Therefore, our results appear to be consistent with previous ESNL studies.   
 The addition of post exercise nutrient (protein) timing did not independently 
appear to significantly influence results.  Indeed, the addition of a control group for post 
exercise nutrition (although not particularly necessary within the parameters of our 
study) may have been of interest.  Pertinent trends did appear intriguing.  However, post 
exercise timing of intake did not appear to independently influence FSR results. 
Significant time effects were seen in body mass, fat mass, and body fat, yet no 
significant group x time effects were observed.  Participants in the delayed intake (D) 
group generally experienced more favorable changes in body mass, fat mass, lean mass 
and body fat.  There were significant time main effect changes for 1RM bench press and 
leg press (with an overall mean percent change).  No significant differences were seen 
among groups in REE, although values trended slightly downward over time throughout 
 99 
 
the 12 weeks.  No significant nutrient timing x training interactions were observed on 
muscle FSR expressed as a percent/day of the alanine pool.  However, FSR was 
augmented in response to a bout of RE prior to training and tended to be 54% higher in 
response to a bout of exercise after training when compared to pre-training values. 
Considering the bulk of previous investigations surrounding protein synthesis 
and resistance training, it is possible that, had we measured FSR over the immediate 
time following exercise (up to 3h), we may have observed more clear evidence 
supporting FSR elevations.  However, considering our RIPT exercise design compared 
to the majority of other NT/FSR studies utilizing a resistance only intervention, this does 
not appear to be a fair comparison.  It has been shown that protein synthesis begins to 
plateau at/or about the 24hr time point[18,268].  Based on our observations, adequately 
controlling dietary demands during a training cycle may offset (at least in part) any 
metabolic need that post-exercise nutrition might provide toward up-regulation of 
muscle protein synthesis.   Hypothetically speaking, if all metabolic needs/energy 
reserves are adequate (on board) via a well-managed diet, there may be no need for a 
nutrient “boost” to meet the metabolic demands of a particular bout of exercise or its 
subsequent recovery period for our population of study.  
Perhaps most interestingly as it pertains to our study, an earlier (2006) similar 
investigation suggested that post exercise intake may be more influential than total daily 
protein intake as an effective method for maintaining FFM during periods of either 
increased energy expenditure (e.g. exercise) or “marginal” protein intake [108].  
Subjects of said study included (in addition to 22 men of the same age range) untrained 
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(≤ 3 hours/wk) women (n=30, 60-69 years) who participated in a 12 week moderate 
resistance exercise (RE) program.  The post exercise supplement consisted of a HP 
beverage composed of 240 kcals (15 g protein, 33 g CHO, and 6 g fat per 8 oz.) or an 
alternate, presumably equivalent supplement (3 subjects who were intolerant of the 
supplement) given immediately post exercise in an amount corresponding to 0.4 g of 
protein/kg of FFM.  This approach seems particularly related to the type of routine 
proposed during our study with a few notable variations.  Examples being, number/type 
of dietary data collection (food logs, etc.), variability of post exercise protein intake, 
exercise programming (active vs. passive rest, aerobic component etc.), macronutrient 
profile of post exercise intake, dietary controls, etc. The authors suggested that a 
randomized double-blind study would be necessary to confirm the reported results.   
 While solid foods may provide the required nutrients, a liquid may assimilate 
more rapidly, make it easier to achieve the preferred ratio, and thus more efficiently 
meet the 2-hour window.  It has been reported that the anabolic phase, wherein the 
optimal effects of nutrient ingestion begins to deteriorate, or close within 45 minutes 
post exercise, peaks within 15-30 minutes post exercise [229].  The general premise is 
that by consuming critical nutrients [e.g. carbs, protein (or specific amino acids), and 
perhaps vitamins] during a time sensitive window, one might spare muscle glycogen, 
achieve greater muscular endurance, stem the rise of the catabolic hormone cortisol 
(hence reducing muscle damage), and facilitate a more favorable environment for 
efficient recovery following exercise. 
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 Finally (perhaps conveniently), a recent meta-analysis addressed the effects of 
protein timing on muscle strength and hypertrophy[264].  Therein, 23 studies with an 
average “Physiotherapy Evidence Database” (PEDro) scale rating of 8.7/10 (High 
Quality) were analyzed.  Of the 23, only one[269] included a sample of older untrained 
women, and the total sample of 34 included men and women aged 57±7years.  Study 
participants were randomly assigned to one of two groups for the 16 week intervention.  
Either an “immediately” pre RT exercise, or an “at least 2h following RT” meal group 
wherein a HP meal (860 kJ, 21 g protein, 0.7 g fat, 29.6 g carbohydrate) energy 
restricted diet was ingested. Considering that 1) the energy restricted dietary profile, 2) 
the focus on type 2 diabetes, and 3) no protein syntheses analyses were undertaken, it 
does not appear that we can draw any direct comparisons between these results and ours 
with regard to protein synthesis.  Arguably, the Shoenfeld et al. meta-analysis, wherein 
most all samples were of younger males participating in a progressive resistance training 
program, and does not include consistently comparable timed intake or dietary profiles 
could be determined to depict a reasonably suitable study of reference when considering 
our results.  However, in consideration of the body of work with regard to protein 
synthesis/FSR response to pre/post exercise nutrition in general as presented within our 
study, it is worthy to mention: the meta-analysis suggested “a majority of any gains in 
muscle mass would have been due to higher protein consumption by the treatment 
group.”   
 Perhaps one of the most pertinent findings lay in data addressing the impact of 
protein timing on hypertrophy, adjusted by protein intake as depicted in Figure 9.  
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Although reported as non-significant, graphically these data appear supportive of dietary 
intake as more critical than timing.  Nevertheless, a follow up “comment” on the 
Shoenfeld Meta-Analysis[271] suggested that: 1. the included studies afforded no 
reasonable assessment of whether timing of protein intake around exercise was 
beneficial because higher total daily protein intake is a confounding factor, and that 2. 
the authors’ assertion that the study had “good statistical power” due to the sample size 
of about 500 subjects is flawed due to the use of only 3 “relevant” studies. 
 These findings are perhaps consistent with a slightly earlier study[270] which 
reported that protein supplementation alone (although timing effects were not evaluated) 
produced beneficial adaptations when combined with resistance training.  Shoenfeld et. 
al. posited that their results directly lends support suggestive of the possibility that 
meeting target protein requirements is paramount to exercise induced muscle protein 
accretion, whereas timed pre and/or post-workout intake may, at best, be a minor 
consideration.  There does appear to be a void when it comes to studies centered around 
the exploration of potential nutrient timing benefits on FSR when it comes to a 
population such as ours. 
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Figure 11. Timing Effects Adjusted for Protein Intake 
Schoenfeld et. al. Journal of the International Society of Sports Nutrition 2013, 10:53 
Conclusion 
Our study investigated pre and post exercise acute and 24hr mixed skeletal 
muscle fractional synthesis rates in obese post-menopausal women as influenced by diet, 
resistance interval program training (RIPT) and post exercise timed ingestion of a 
commercially prepared protein shake over a 12 week training cycle.  Admittedly, a 
limitation of this study, in addition to those enumerated earlier was our small sample 
size. Therefore, we can neither confirm nor deny the possibility that immediate (or 
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delayed) post-exercise protein consumption were responsible (or to what degree) for 
observed increases in protein synthesis within or between groups.  Thus, more work with 
larger sample sizes in this area focusing on pertinent protein pools and nutrient timing 
should be conducted. 
 Nutrient timing does not appear to influence 24-hour FSR, body composition 
changes, and/or training adaptations in women participating in resistance interval 
program training (RIPT) while trying to promote weight loss.  Other studies have not 
focused on determining if nutrient timing influences FSR or training adaptations in 
women using resistance exercise and a higher protein diet as a means of preserving FFM 
and REE during a weight loss trial.  Other studies have focused on attempts to increase 
FFM without a hypo-energetic diet. 
 Participation in our exercise and weight management program with the addition 
of timed post-exercise nutrition may indeed promote more favorable changes in body 
composition.  In consideration of the trend toward greater results in the 2hr post exercise 
timed group, a more delayed time of ingestion may be preferable to immediately post-
exercise ingestion within our population of interest.  With a relatively higher protein 
intake compared to previous studies, it also seems plausible that the post exercise intake 
may have boosted overall dietary protein intake, although target values were not 
achieved via assessment of our four 4-day food log records.  Our results suggest that we 
are unable to conclude that post exercise protein consumption is responsible for the 
results achieved during this study.  As discussed earlier, perhaps total dietary protein is 
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all it takes to get the job done as long as nutritional intake is appropriately well managed 
in a population such as was employed within this study. 
 Ultimately, our findings suggest that rather than the timing of ingestion, daily 
nutrient (perhaps more specifically protein) intake may be of equal interest when it 
comes to maintaining muscle protein anabolism with exercise.  Future free living model 
research in this area might focus on larger sample sizes and additional controls to 
examine whether nutrient timing (NT) affects health related training adaptations in post-
menopausal overweight women (or aged males) who participate in lower carbohydrate, 
fat and higher protein diet interventions wherein these types of resistance interval 
program training (RIPT) designs are implemented. 
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Table A4. 2H-labeling of body water and skeletal muscle protein (T-1). 
  
                  Plasma (MPE)                   Mixed SM (MPE) 
Subject             Pre          7.5 h          9.5 h          24 h               Pre        Post      
24hr
  
1  0.019     0.379         0.366         0.481  1.086     0.464    0.417 
2             0.017     0.444         0.427         0.541            0.049     0.114    0.929 
3  0.026     0.318         0.369         0.497  0.092     0.261    0.486 
4             0.014     0.341         0.348         0.496  0.114     0.041    0.058 
5  0.029     0.385         0.382         0.520  0.078     0.040    0.089 
6  0.021     0.396         0.393         0.505  0.179     0.269    0.375 
7             0.026       0.384         0.383         0.524  0.232     0.108    0.114 
8             0.015     0.299         0.376         0.499             
9  0.027     0.389         0.391         0.503  0.080     0.633    0.147 
10  0.012     0.401         0.390         0.493  0.378     0.065    0.208 
11  0.019     0.384         0.391         0.521  0.184     0.137    0.485 
12  0.015     0.385         0.400         0.480  0.324     0.279    0.083 
13                    0.042       0.360         0.357         0.492            0.533     0.355    0.634 
14                    0.009       0.360         0.365         0.513            0.098     0.052    0.123 
15                    0.003       0.401         0.397         0.532            1.161     0.616    0.327 
16                    0.027       0.386         0.367         0.468            0.093     0.455    0.106 
17                    0.020       0.342         0.352         0.479            0.073     0.083    0.144 
18                    0.030       0.361         0.390         0.479            0.167     0.457    0.301 
19                    0.025       0.347         0.357         0.468            0.161     0.042    0.196 
20                    0.023       0.392         0.375         0.507            0.041     0.456    0.119 
21                    0.018       0.344         0.366         0.526            0.102     1.509    0.634 
22                    0.019       0.297         0.325         0.448            0.191     0.220    0.602 
 
Mean  0.021     0.368*       0.376*        0.499*   0.258     0.317   0.313 
SEM                0.017       0.075        0.046          0.050             0.068     0.073   
0.052
  
Plasma 2H labeling measured prior to the start of the study (0h), 1h post-exercise 
(+7.5h), 3h post-exercise (9.5h) and 16h post-exercise (+24h) in the plasma, and 2H 
labeling of protein-bound alanine measured 16h post-exercise (+24h).  MPE = mole 
percent excess.  *Plasma 2H labeling was significantly higher at 7.5, 9.5 and 24 h than 
pre (time 0) values, p < 0.001.  
 
 
 
 
 
 
 135 
 
 
 
 
  
Table A5. 2H-labeling of body water and skeletal muscle protein (T-2). 
  
                   Plasma (MPE)       Mixed SM (MPE) 
Subject             Pre          7.5 h          9.5 h          24 h               Pre     Post        24 
hr
  
1  0.021     0.404         0.377         0.497  0.191   0.251      0.265 
2             0.036     0.415         0.403         0.519            0.228   0.219      0.261 
3  0.025     0.404         0.389         0.518  0.762   1.930      0.522 
4             0.018     0.394         0.381         0.500  0.231   0.198      0.277 
5  0.186     0.388         0.390         0.563  0.213   0.296 
6  0.021     0.426         0.416         0.540  0.358   0.472       0.666 
7             0.035       0.382         0.379         0.505  0.206   0.252       0.271 
8             0.030     0.365         0.372         0.495          0.242    0.567       0.259 
9  0.025     0.376         0.360         0.464  0.196    0.232      1.196 
10  0.023     0.388         0.385         0.504  0.222    0.224      0.255 
11  0.031     0.377         0.378         0.498  0.271    0.253      0.261 
12     
13                    0.028       0.407         0.395         0.522            0.497    0.281      0.324 
14                    0.192       0.370         0.382         0.488            0.231    0.216      0.305 
15                    0.244       0.403         0.398         0.537            0.887     0.352     1.474 
16                    0.028       0.388         0.387         0.503            0.179     0.153     0.201 
17                    0.022       0.414         0.398         0.493            0.286     0.263     0.279 
18                    0.022       0.382         0.368         0.546            0.249     0.287     0.261 
19                    0.017       0.356         0.355         0.487            0.158     0.229     0.222 
20                    0.033       0.399         0.398         0.528            0.283     0.197     0.250 
21                    0.024       0.385         0.371         0.496            0.240     0.254     0.334 
22                    0.027       0.372         0.367         0.479            1.229     0.281     0.994 
 
Mean  0.052     0.390*       0.383*        0.510*  0.307    0.349     0.447 
SEM                0.010       0.006        0.004          0.005            0.043     0.082     
0.077
  
Plasma 2H labeling measured prior to the start of the study (0h), 1h post-exercise 
(+7.5h), 3h post-exercise (9.5h) and 16h post-exercise (+24h) in the plasma, and 2H 
labeling of protein-bound alanine measured 16h post-exercise (+24h).  MPE = mole 
percent excess. *Plasma 2H labeling was significantly higher at 7.5, 9.5 and 24 h than 
pre (time 0) values, P < 0.000.     
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